Other,negativelyCorrelatedWithLvef
Other,cosmesis
Other,50PercecntRelapsedTissues
Other,twoUncommonCasesOfDelayedBreastCancerRelapses
Other,aberrantExpressionOfBIn21PercecntRespectively
Other,womenInWorld
Other,utilized
Other,survivalOfCellsInVitroAndInVivo
Other,mir-193b-3pBindingTo3UntranslatedRegionOfMorc4
Other,affected
Incorporation,inStudyFusedWithMouseMyelomaCellLineSp2/0InPresence
Other,littleSurvivalVariance
Other,failure
Other,trials
Other,managementOfTumour-relatedSymptoms
Lymphedema,lymphedemaPatients
Other,hasAssociatedWithPoorCancerScreeningUptake
Resistance,breastCancerCellMigration
Other,valueOfErbeta-targetedTherapies
Other,tumorSites
Other,shallow-CNN
Endocrine,canEffectivelyTreatedByEndocrineTherapy
Endocrine,thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas
Other,Uganda
Other,oneRegionAnother
Other,breast
Other,anotherOfSeveralIndividualsInOneFamilyAffectedByCs
Incorporation,retrospectiveStudyOfPatientsWithCa-vte
Incorporation,perceivedWorkAbility
Other,reverseTranscriptionQuantitativePolymeraseChainReaction
Provision,follow-up
Other,extensiveMolecular
Other,resultOfPresentationWithAbnormalUterineBleeding
Other,16PrimaryBreastCancers
Other,a549Cells
Other,underway
Other,hybridChemicalProteomicsApproachTermedByEngineeringSrcHomology2
Other,proteins
Other,usedAtOurInstitutionForSelectPatientsWithGoodOutcomes
Other,inOfGamma-ggtTransformedIntoNir-sn-nh
Other,usuallyAssociated
Other,differentiallyExpressedCircularRnasInNeurologicalDisorders
Other,associationsWithDiseasesLikeTypeI
Other,decreasedRiskOfBreastCancerInFemaleAdPatients
Other,accessToReceptorAnalysesInCytosolAtDiagnosis
Other,lymphaticInvasion
Other,metastaticAdenocarcinomaFeatures
Other,differentGeneticProfile
Other,pathologicallyTumor-freeNodes
Other,commonMalignantDisease
Other,treatmentTherapy
Other,synchrotronRadiation
Other,uncommon
Other,CTIBL
Other,shouldPerformedInAtRisk
Hyperglycemia,novelStrategiesForDiagnosisOfBreastCancerWithHyperglycemia
Other,long-term
Other,visits
Other,sufferingFromWoman'sDisease
Other,primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs
Other,from33ObservationalStudiesExposedToTrastuzumabTherapy
Other,cutoffValues
Other,inMultivariateModelsRelatedToPerformanceStatus
Other,11Days
Other,article
Other,rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects
Other,throughOptimizationTestsChosenAsOptimalConditions
Other,oneFamilyAffectedByCs
Other,effectiveDiagnosisOfBreastCancer
Document,model2
Other,results
Other,WHI
Other,mostLikelyParaneoplastic
Sleep,medianAgeOf50
Other,diseaseDiagnosis
Other,properAccessToDiagnosis
Other,transferable
Interference,assessment
Other,patientsWithProlactinoma
Other,novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis
Other,controversial
Other,evidence
Other,challenge
Other,evenNeeded
Distance,firstSymptom
Other,substantialSubsetOfTotalSample
Other,alsoAssociated
Other,reduction
Other,activatedComplex
Other,growth
Other,C1
Other,heterogeneousCancerInFemalePatientsWorldwide
Other,Ontario
Other,apoptosis
Other,rates
Other,thereforeUrgentlyNeeded
Other,tumorGrowthInExperimentalModels
Other,those
Exosomes,isolatingExosomes
Other,frequentInformationalNeeds
Other,pi3k-aktSignalingPathway
Other,generalHealth
Lifestyle,proposedTotal-variationSchemeWithSpatially-varyingAnisotropicWeightingCompensateForGeometricBiasFromLimitedAngleImagingSetup
Resistance,physicalActivityInPatientsWithMetastaticBreastCancer
Other,independent
Other,FFDM
Other,data
Other,diagnosisInMajorityOfInconclusiveCases
Other,currentlyInsufficient
Other,clinicalCare
Other,pathogenesisOfBreastCancer
Other,threeDifferentUsMachines
Other,respectivelyFound
Other,moreInformationAboutFurtherStratificationOfBreastCancerSubtypes
Other,patientsWithSmall-cellLungCancer
Appearance,caseOf75-year-oldPatientWithDuctalInfiltratedCarcinoma
Other,pax6GeneExpression
Other,elderlyPatientWithRelapsedHer2
Other,predictive
Other,obtainedFromMedicalSpecialists
Other,monitoredOnDailyBasis
Other,hasObserved
Other,regulationOfEnergyMetabolism
Other,advantages
Other,pb-ctMode
Other,trastuzumab
Other,delaysinTreatment
Other,outcome
Other,T2
Probe,probe
Other,thereforeVeryPromisingStrategy
Images,opticalCoherenceTomographyImages
Other,pertinent
Exposure,enlargement
Other,comparable
Other,ultrasound
Other,whenSevere
Incorporation,multicenterStudy
Other,ICER
Other,similarlyInPancreaticCancersHaveSuggestedAsDiagnosticBiomarker
Other,usuallyLong-term
Other,improved
Other,managed
Other,researchers
Other,heterogenous
Other,adulthood
Other,detected
Incorporation,ourStudy
Other,estimates
Other,mayImportantStepsDuringDiagnosis
Other,associationsOfFactorsWithLocoregionalAtDiagnosis
Other,calculated
Other,preventionOfBreastCancer
Other,primaryBreastCancer
Other,hasDescribedInFewHdgcFamilies
Markers,markersOfMesothelioma
Other,40Percecnt
Other,active
Sleep,influenceOfSleepQualityOnPmInPatientsTreatedWithHt
Baseline,patientsWithReducedBaselineLvef
Other,evenAdjustedForKnownPrognosticFactors
Other,breastCancerPatientsSerum
Provision,overLastYearsHaveProposedAsBiomarkersForCancerDetection
Food,itParticularlyAttractiveAsPotentialAgentInBreastCancerPrevention
Other,diagnosisOfEstrogenReceptor
Other,alteredInHumanBreastCarcinoma
Other,modulated
Other,increasedRisk
Resistance,heterogeneousExpressionOfHumanEpidermalGrowthFactorReceptor2OnIndividualCancerCellSurface
Other,tumorSite
Other,effectivenessOfDifferentNpatsOnQolInPatientsWithBreastCancer
Other,PFS
Craniotomy,surgicalExcisionWithRadiation
Sleep,furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
Other,higher
Endocrine,dealingWithEndocrineResistanceInPatientsWithBreastCancer
Resistance,weakToStrongReactivityToOtherCellLines
Other,cancerClassification
Other,improvedDiagnosis
Other,MRI
Skin,expressionLevel
Other,reviewed
Other,costOfMriExamination
Other,incidenceAmongMalignancies
Other,higherDetectionRatesOfArchitecturalDistortionParticularlyInPatientsWithDenseBreastTissue
Other,healthcareCost
Other,oneRegion
Other,inspection
Other,criticalImplicationsForTherapeuticDecision-makingInUrothelialCancer
Other,464Percecnt
Drugs,developmentOfNewDrugs
Other,achieved
Other,importantInsightsIntoDiagnosisOfPatientsWithDisease
Other,update
Other,successfulFunctionalizationOfNanocompositeOfSpecificSequenceOfAminatedComplementaryOligonucleotideOfMirna-21
Other,avoidance
Interference,evenLessFrequentComplication
Other,studies
Other,presence
Extract,mostCommonExtrinsicCause
Lymphedema,higherProportionOfPatientsWithLymphedema
Other,patterns
Other,bioinformaticAnalysis
Other,moreDirectional
Other,thereforeApplied
Other,increasedMalignantPotential
Other,tnmStage
Other,signatures
Other,drugDecay
Other,spectrum
Other,denseBreastTissue
Document,model
Other,23Studies
Other,unnecessaryRepeatBiopsies
Other,3PreviousMalignancies
Document,similarToThatReportedInLiterature
Resistance,theirInterestingBiologicalActivity
Other,increasedDifferentiation
Other,right4
Other,adherenceToRecommendationWith95PercecntConfidenceIntervals
DNA,dnaDamage
Endocrine,patientsWithProstateCancer
Other,forefrontOfResearch
Endocrine,commonlyUsedAntihormonalTherapyInTreatmentOfBreastCancerInPostmenopausalWomenSpecificallyInTreatmentOfHormoneReceptor-positiveBreastCancer
Other,RFFS-GS
Other,methylationStatusOfPcdh10InBreastCancerTissues
Resistance,increasedCellApoptosis
Other,C
Appearance,caseOf39-year-oldManPresentedToUsWithMultipleSuutaneousLesionsOverChest
Other,neoadjuvantAnti-her2Treatment
Resistance,potentAnticancerActivity
Other,fourGroups
Other,retrospectivelyReviewed
Other,incrementalCostOfCop$251049
Other,explored
Other,adherence
Other,patientsWithBreastCancerReceivingWithAnthracyclines
Other,thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s
Other,thatOfOtherCountries
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathwayInSpinalCordInLumbarSegments4-6
Markers,estrogen-receptorAmongOtherMarkers
Interval,fieldOfBreastCancerDetection
Other,gynaecologicalMetastases
Other,0.003
Other,relativeThoseOfControls
Other,pax6MethylationStatus
Other,novelInsightsIntoEpigeneticEvents
Other,continuousDynamicCyclesOfFission
Other,inContextAppliedInClinicalDiagnosticsInClinicalTrialsForPurposeOfStratification
Other,developmentOfBrainCancers
Baseline,proteomeScaleWithHighSelectivity
Other,negativeMargins
Other,higherRisksOfTreatmentDelays
Other,levelsOfEralphaProtein
Other,functions
Other,genes
Other,breastCancerTreatment
Other,mostEffectiveTechniqueused
Other,widelyExpressed
Other,positiveForGata3In93PercecntIn78PercecntOfCases
Other,triple-negativeSubtypeMda-mb-231Cells
Other,informationalNeedsByCancerType
Other,approaches
Hyperglycemia,managedWithPalliativeRightHemicolectomyInViewOfConstipationAsSystemicTreatment
Exposure,itsPerformance
Other,diagnosisOfPatientsWithBreastCancer
Other,conditions
Other,differentLevelsOfCk19
Other,described
Other,hdgcTestingCriteria
Other,percentage
Other,shaped
Other,searched
Other,upregulationOfE-cadherinExpressionLevels
Other,.021
Glycosylation,glycosylation
Other,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Other,serumSamplesFromCancerPatients
Areola,sideEffectsOfBreastCancerTherapiesIncludingHotFlushes
Other,876PercecntRespectively
Other,area
Other,significantChallenge
Other,pi3k-akt-mediatedMitochondrialSignalingPathwayTumorSuppressorMir-10a
Other,limited
Other,risks
Other,positive
Other,factor
Other,areInvestigated
Other,hasFocused
Other,biologicallyDifferentDiseaseInWomen
Other,variousOtherCancerInHumanBody
Other,exposed
Baseline,reducedBaselineLvef
Other,compared
Other,haveBackboneOfSuchEnormousStridesOfAu
Other,13-hDailyOvernightFast
Other,mostEuropeanCountries
Other,family
Other,incorrectDiagnosis
Other,thusAimed
Other,antibody-basedStrategy
Other,developmentOfPolicies
Other,largelyConsistent
Other,severalObjectives
Distance,boneDensity
Sleep,possibleCorrelationsWithClinicalStatusIncludingAge
Drugs,resistanceToAntimitoticDrugs
Other,surgery
Other,good
Other,shouldGiven
Other,pregnancyFrom1959To1966
Disruption,postponementVisiting
Other,mustAddressed
Areola,everolimusSideEffects
Other,factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis
Microenvironment,pro-tumorigenicMicroenvironment
Other,t-MDS
Other,generalBreastCancerPopulation
Other,tumorSuppressorGene
Other,polymorphismOfFok1
Other,differentiallyExpressedInBreastCancerCells
Other,onlyWomen
Other,n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies
Appearance,percentageChangeInIncidenceRates
Other,haveClarified
Other,influences
Other,howeverLargelyUnreported
Other,mayUsed
Plasticity,massInPosteriorFossaOfBrain
Other,alsoAssessed
Other,differentmethodsOfSelf-treatment
Other,adipocytes
Other,510YearsAfterSurgery
Other,stable
Markers,standardMethodForEvaluationOfProposedPrognosticTumourMarkers
Carcinoma,Carcinoma
Other,aberrantlyExpressed
Provision,directActingOralAnticoagulants
Other,strongFamilyHistoryOfCancer
Other,outcomesOfEstrogenReceptorPositive
Other,breastSurveillance
Other,seValues
Other,consequentlyHaveDeveloped
Other,monitored
Plasticity,comparableToContrast-enhancedMriInTermsOfSensitivityAtFractionOfCost
Other,riskOfDeath
Other,theirRisk
Other,treatmentOfEuropeanPatients
Other,haveAllProposedAmongPotentialPathways
Other,assessedinclusionCriteriaForEnrolment
Other,negative
Resistance,attenuatedCellGrowth
Sleep,duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100000DuringAge50-54
Other,dissection
Other,electricalDouble-layerCapacitors
Other,willUsedAsReferences
Other,peripheralBlood
Other,termsOfClassification
Other,detection
Other,enhanced
Obstacle,adjustedHazardRatio
Other,correlated
Other,standardizedDataCollection
Sleep,documentationOfPatientAge
Other,alarm
Other,singleMetastaticSite
Other,hasReduced
Other,additionalAnti-her2Therapy
Mother,acuteDangerToMother
Other,an
Other,breastCancerYoungerThan45Years
Other,widelyKnown
Plasticity,sensitivityOfDrug-resistantCellsToChemotherapeutics
Other,imagingFeaturesOfCommon
Interference,urgentlyAdvanceImplementation
Other,therapies
Other,able
Skin,twoCasesOfMimicsOfBoneMetastasis
Other,danger
Other,humanLife
Other,ca15-3ByCmia
Other,whereNeeded
Other,overallCumulativeRiskOfProgression
Almaty,howeverGreaterforPatientsTreatedInAlmatyCity
Other,developmentOfGraphicallyTailoredScreeningTool
Other,additionallyRevealed
Neuropathy,generallyFibrosis
Other,992Percecnt
Other,prognosticFactorIndependentOfOtherClinicalVariables
Other,particularEmphasisQuantifying
Other,times
Other,effectsOfPcosOnRisksOfGynecologicCancer
Other,system
Other,healthyWaysOfLife
Other,widerPopulationOfPatients
Other,currentResults
Other,sparseCombinationOfRiemannianDictionaryAtoms
Other,mostFrequentCancerInWomenTreatedWithHormonalTherapy
Other,recognized
Other,about1Year
Other,mitosisDyingByMitoticCatastrophe
Provision,criticalScientificBaseForPrecisionMedicineInBreastCancer
Other,adenocarcinomaFeatures
Document,thatReportedInLiterature
Microenvironment,imbalanceInCytokineProfilesInPro-tumorigenicMicroenvironment
Other,proposed
Other,proposedForBreastTumorGrading
Other,significantlyProlongedMedianPfs
Other,576Percecnt
Other,howeverNon-ideal
Other,typicalImagingPattern
Resistance,chemotherapyResistance
Other,lowIncidence
Other,ourFacility
Other,mistaken
Nondestructive,byWhichObservedInNondestructiveWayThroughThermalAnalysis
Other,indispensable
Other,appliedTo70PatientsWithUnilateralRl
Other,survival
Other,itsMinimalSilverIonReleaseProfiles
Document,formOfApoptosis
Other,otherSubtypesOfBreastCancer
Other,analysisInvestigate
Other,potential
Other,0.007
Other,incidenceOfCardiovascularDiseaseAmong32757CancerSurvivors
Other,breastCancerClassification
Infrared,moreResearchLight
Other,worldwideHighestAge-standardizedBreastCancerIncidence
Other,28Segments
Other,nowGreater
Other,increasedRiskOfLong-termIncidentcvd
Other,NMA
Behaviours,changesInHealthBehavioursAfterBreastCancerDiagnosis
Other,mainlyObserved
Other,mainlyPostmenopausalWomen
Other,adultPatientsDiagnosed
Other,crucialRole
Plasticity,sensitivityOfMda-mb-468ToChemotherapeutics
Other,selected
Other,consensus-based
Other,alternativeToFrozenSections
Other,CNVs
Other,reported
Other,skullLesions
Other,understudiedPattern
Other,progressionOfTumorInvasionInBreastCarcinoma
Other,risingTrendOfColorectalCancers
Other,real-worldSetting
Other,powerfulToolForEarlyDetection
Other,connection
Other,descriptive
Other,whenonlyAnalyzed
Appearance,appearance
Other,diagnosis
Other,associations
Other,her2/hrTripleNegativeTnmStages
Other,underutilized
Other,6Years
Other,additionallyCorrelated
Provision,lastFourDecades
Other,familyHistory
Other,HeLa
Other,proxyForcvd
Interval,state-of-the-artImageAnalysisMethods
Other,promising
Other,elusive
Other,diagnosisOfCancer
Other,recentlyDiagnosedBreastCancer
Interval,correspondingHistologyImage
Other,hidden
Other,toxic
Other,unitedStates
Exposure,finiteSamplePerformanceOfProposedMethods
Other,haveProven
Other,26/31
Other,subsequentLung/bronchusMalignancies
Other,performed
Interference,chronicDebilitatingLifelongComplication
Other,95PercecntCi646-779Percecnt
Other,clinicalPractice
Interval,cellCycleArrestFollowedByMassiveCellDeath
Interference,finalAssessment
Cytology,breastCancerGeneticsInKenya
Other,imagingInvestigations
Interval,observedInTransfectionGroup
Other,mammalianBrainTissues
Other,38Months
Resistance,modestAnti-tumorActivity
Other,significantEnrichmentOfCdh1MutationsWithinEcDomainsInComparisonToCdh1MutationsAssociatedWithHdgc
Other,correlationCoefficientOnMetabricTrainingSet
Relapse,betterOutcomeWithGoodNegativePredictiveValue
Document,copyright
Other,pathologicEvaluation
Other,collectedFromElectronicHealthRecord
Other,spindleCells
Other,assessedPreoperatively
Interference,scalableIntervention
Other,methylSpecific-multiplexLigationProbeAmplification
Other,approximated
Other,Kiel
Other,cervical
Other,globalHealth
Other,potentialImportanceAsModelsForHumanBreastCancer
Other,3-timeAssessments
Other,rare
Other,tumorImaging
Provision,oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction
Other,likely
Other,metastasesFromDistantPrimaryTumors
Other,occurrenceOfBreastCarcinoma
Other,body
Other,fewerInstancesOfSpreadToLungs
Other,widespreadInterest
Other,lowRiskLesions
Other,relativesOfPatientsWithPa
Markers,markers
Other,recentPatternsInIncidenceRatesForMajorCancerSitesInAdults
Other,normalSamples
Other,usualCare
Other,twoLargeBreastCancerDatabases
Other,theirParticularity
Other,successfullyUsed
Other,public
Other,whereFormulated
Other,inBreastTumorsKnownAsBreastCscs
Other,sufficient
Neuropathy,relationToOccurrenceOfOsteoporosisAmongVariousEthnicGroups
Other,clinico-epidemiologicalFeaturesOfBreastCancer
Other,associationOfPcdh10Methylation
Other,bortezomib-inducedColdAllodynia
Other,magneticResonanceImaging
Food,furthermoreCouldDevelopedAsPotentialTherapeuticAgentAgainstMcf7-cell-related
Other,suppressionOfBreastCancer
Other,1999-2011
Other,twoGroups
Other,molecular
Other,fiveYearsPosttreatment
Other,tumourSpread
Other,masses
Neuromas,only35CasesOfTraumaticBreastNeuromas
Other,heterogeneous
Other,breastCancerIncidence
Other,244GermlineVariants
Other,mechanism
Other,importantProblem
Other,place
Other,venaCavaSyndrome
Other,relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt
Other,expected
Resistance,resistanceToExistingTherapies
Other,sameRangeAsCasesWithoutWavelength-dependentMeasurementErrors
Other,disseminatedDisease
Other,DOACs
Other,hasPut
Other,contrastRatio
Other,cxcSubtypeOfChemokineSuperfamily
Other,part
Areola,variablesPredictiveOfNippleAreolaComplexInvolvementInPatients
Other,incidenceFactorsOfSubsequentLung/bronchusPrimaries
Capillaries,bareCapillaries
Other,country
Other,immediateUnmetNeedInClinicalPractice
Other,inPreprocessingHasAchieved
Other,YS
Other,incision
Other,255Months
Other,canExtended
Other,usuallyPerformed
Other,earlyDetectionOfSeveralCancerTypes
Other,thenAdded
Other,potentAnticancerEffects
Other,detectionRate
Other,certainCancers
Distance,characteristicsInsideTumors
Other,year
Other,resultOfPreviousOrbitalBiopsy
Other,correlativeEntities
Other,veryRareCases
Mastectomies,bilateralTotalMastectomies
Plasticity,massSpectrometry
Other,dual-energyAcquisition
Other,youngerPeople
Other,6Months
Other,predominant
Other,exceedinglyRare
Other,modelling
Interval,cellCycleRegulators
Other,comparedBetween2GroupstheApatinib
Plasticity,discoveryOfBiochemicalSignaturesMeasuredByMassSpectrometry
Other,concerns
Sleep,significantlyYoungerAge
Other,lentivirusTransduction
PET/CT,subgroupAnalysispleuroparenchymalAnomaliesRateDetectedOnF-fdgPet/ct
Infrared,infraredFluorescentImagingInTripleNegativeInVitro
Other,uncouplingOfInverseCorrelationBetweenBmi
Other,505Percecnt
Provision,breastCancerControlEffortsForIdentification
Other,designed
Pediatric,pediatricPopulation
Interval,energyImage
Other,haveConducted
Other,useOfAdvancedImagingExaminations
Endocrine,largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
Other,discovered
Document,randomEffectsModel
Other,Kenya
Other,histopathologicalDiagnostics
Behaviours,positiveChangesInTheirHealthBehaviours
Other,selectedPopulationsOfAfricanPatients
Appearance,643PercecntWithSignificantDifferenceBetweenWhites
Other,long-termEstimates
Other,reductionOfFpsFrom085002Fp/imageForMias
Other,two-thirdsOfBreastCancerCases
Applicability,clinicalApplicabilityOfOurMethodInBreastCancerImagingSetting
Other,highestIncidenceAmongMalignanciesDiagnosedInWomen
Other,iU22
Other,persistentPain
Other,involvementOfPtenInCs
Interval,period
Other,effectsOfTreatment
Other,centralRoleInBreastCancerResearch
Other,revisionsOfAjccBreastCancerStagingSystem
Resistance,capacity
Other,tumorBurden
Other,divided
Other,pathologistAnnotation
Other,advancedBreastCancerTreatment
Other,needForAnalysisOfMetastaticTissuesAtRecurrence
Other,her2-positiveA
Other,768PercecntSamplesWithOverexpressionIn76Cases
Other,transformed
Other,their
Other,medical
Ethanolic,freshLeafEthanolicExtract-treatedMda-mb-231Cells
Other,risingTrendInMajorityOfLmics
Other,99PercecntOfCases
Other,circumferentialNarrowingOfCaecum
Other,tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer
Other,shouldProcessed
Other,asymptoticPropertiesOfEstimatesCalculatedFrom
Other,unusualPresentationOfSuperiorVenaCavaSyndrome
Other,couldSutegorized
Other,practitionerDecisionmaking
Other,18.791
Other,haveDeveloped
Other,forThoseWithNormalLvef93Percecnt
Other,haveObserved
Other,regulated
Other,dualRoleOfL-3InBl1-subtypeTriple-negativeBreastCancer
Other,canUsed
Other,knownHeterogeneousDisease
Sarcomas,softTissueSarcomas
Extract,treatmentBenefitWithTrastuzumabTherapyForBreastCancer
Other,canDetectedInManyBodyFluidsIncludingSerum/plasmaSamples
Other,highPercentageOfRemissionMaintenance
Incorporation,descriptiveStudy
Other,cancerPatients
Other,needForNodalRadiotherapyInSpecificSituations
Other,nf-krab-inducedIncreasedExpressionOfCcnd1
Other,clinicalSetting
Other,moodOfLife
Other,percecntRelapsedTissues
Similarities,similaritiesOfInformationRequired
Other,protectiveRoleOfRs5743810
Cavernous,twoCasesOfCavernousMalformationFormationYears
Other,sometimesMistaken
Food,henceMajorResearchGoal
Other,given
Other,phosphoinositide3-kinase
Infrared,secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
Incorporation,presentStudy
Other,administered
Other,PCI
Other,192Months
Other,significance
Other,treatmentMoreAccessibleToBreastCancerPatients
Other,appropriateDiagnosisOfBreastCancer
Interference,interventionArm
Other,necessary
Food,hotIssueInFieldOfCancerClassification
Other,progression-freeSurvival
Other,bleedingRisk
Other,30TBreastMagneticResonanceImagingExaminations
Other,normalCardiacFunction
Other,generalPopulation
Other,trendsInUkCancerIncidenceByCancerSite
Other,shouldGivenToGeriatricOncology
Other,optimalParametersInFeatureSelectionProcess
Neuropathy,chemotherapy-inducedNeuropathy
Neuropathy,lesion
Other,widelyAcceptedAsStandardOfCareFollowingBreastConservation
Other,MP
Other,MortalityRates
Other,identifiedAsMostEffectiveMolecules
Other,molecularDiagnosisMethodMake
Other,treatedWithIntraperitonealInjectionFor30Days
Other,burdenOfCervicalCancer
Other,imaging
Other,mostInvasiveDisease
Other,higherRiskOfBleeding
Other,formulationOfEffectiveManagementPlanForAt-riskWomen
Quantification,observation
Other,suggested
Other,thromboembolicEvents
Other,measured
Other,treatedWithCapecitabineMonotherapyAsThird-lineTherapy
Other,time
Other,oftenHypomethylated
Other,differentOss
Other,imagingModalities
Other,relevant
Other,signalAmplificationStrategies
Other,relationship
Other,whenIntegratedWithinCountry/region'sHealthPlan
Other,least
Other,properties
Other,exactTest
Obstacle,coxProportionalHazardModel
Other,needs
Other,moreCommonlyDiagnosed
Other,worseOsThanT2aSutegory
Other,initialPresentationOfInvasiveBreastCancer
Other,immune-mediatedCancer-associatedDisorders
Other,examined
Other,SE
Resistance,breastCancerCellInvasion
Other,Israel
Other,autosomal-dominantlyInheritedCancerSyndromeAssociatedWithRiskCausedByHeterozygousCdh1GermlineMutations
Skin,growthOfCancerCellsInSkinOriginatingFromInternalCancer
Other,regulationOfEmtProgressionOfSnaiFamilyMembers
Other,canClassified
Other,howeverMaySometimesDifficult
Neuropathy,mayIndicativeOfBenignLesion
Other,haveProducedInLaboratories
Other,brainMetastasisFromPapillaryThyroidCarcinoma
Other,concomitantlyShouldAnalyzed
Collision,potentialImpactOnFertilityAfterTreatment
Other,desirable
Other,91Percecnt
Other,identificationOfDistinctiveGeneticModificationsInDifferentBreastCancerMolecularSubtypes
Other,normalTissues
Polymorphisms,resultsOfIndividualVdrPolymorphisms
Other,713Percecnt
Other,overexpressed
Other,significant
Extract,benefitOfProtectionAgainstCardiovascularEventsWithPotentialReductionInBreastCancerRisk
Other,support
Other,5CmLess
Other,thereforeHasAppliedToEarlyIdentification
Other,efficacy
Other,differentSubtype
Other,workflowConsistingOfImmunoaffinityPurification
Other,furtherFound
Other,demonstrate
Other,clinicopathologicalFeaturesOfT-mnPatients
Infrared,researchLight
Other,comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies
Other,sample
Other,available
Issues,issuesOfExistingContrastAgents
Other,higherRatesOfMisdiagnosisForBreastCancer
Other,variousStimuli
Collision,greatClinicalImpactForTumorDiagnosis
Other,administrationOfNeoadjuvant
Food,patientEducationIdentification/reportingOfSideEffects
Drugs,drugs
Other,haveYetProven
Other,geneticMalignancyPredispositionSyndrome
Other,sw-22
Other,axillary
Other,autonomyOfPatients
Other,shouldCo-managedByCardiologist
Other,evidencedByIncreaseInContrastAfterInjection
Other,treatments
Other,shouldTested
Other,identificationOfPredictiveBiomarkersForSelectionOfOptimalTreatment
Other,canineTumours
Issues,issuesRelatedToTherapeuticSequencingInLocalTherapyOfBreastCancer
Other,decreasedGrowth
Other,benignBreastLesions
Other,patientWithEarlyBreastCancer
Other,options
Sleep,womenOfReproductiveAge
Other,limitedNumberOfCases
Other,breastCancerTissue
Other,canDifficult
Exposure,hemorrhagicEnlargement30YearsAfter
Other,themselves
Other,dataOfN=
Other,riskOfOtherLongTermAdverseHealthSequelae
Interval,increasingCellCycleGeneExpression
Other,femaleSibling
Other,development
Areola,surgicalOptionsIncludingPreservationOfNippleAreolaComplex
Other,Japanese
Other,itsUse
Neuropathy,infiltrativeLesion
Other,oftenRelated
Other,frequent
Other,multiyearCollaborationLedByUnionForInternationalCancerControl
Other,computedTomography
Other,inLongTermHasFound
Other,established
Other,matthewsCorrelationCoefficientOf8038Percecnt
Other,imperative
Other,vitalRole
Distance,shouldIdeallyAdministeredAtLeast1WeekBeforeCommencementOfAlkylatingTreatment
Other,mightPromisingTherapeuticStrategyForHormone-therapyRefractoryEr
Resistance,transcriptionalActivityOfHypoxia-inducibleFactor1
Other,mutationalStatusBesidesFamilyHistory
Other,thoughtfulMultidisciplinaryPlanning
Other,haveReportedMainlyAfterMastectomy
Other,health
Other,earlyCancerDiagnosis
Provision,site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells
Other,highlySensitiveNano-biosensor
Other,shouldAdministered
Other,percent
Other,excision/lumpectomy
Other,therapeuticEffectsInBreastCancer
Sleep,inTotalDiagnosedUnderAgeOf50
Other,eukaryoticTranscriptome
Other,largeNumberOfTumor-freeData
Lymphedema,outcomeInLymphedemaPatients
Other,offered
Other,imagery
Other,alsoShaped
Other,itsWidespreadUse
Other,rareSubtypeOfDllWithLimitedDataOnPatternsOfFailure
Resistance,greatPotentialOfClinicalApplication
Other,causal
Other,1
Other,womenWithG
Other,tool
Other,featureMiningFromRois
Appearance,accuracy
Other,focalNeurologicDeficit
Other,0.46
Resistance,inhibitionOfCellProliferation
Other,geneExpressionUpregulationInBreastCancer
Plasticity,one-waySensitivityAnalyses
Users,users
Incorporation,retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000
Other,rarelyMayDetected
Other,713PercecntWithHighHeterogeneity
Other,moreRecentlyHaveDeveloped
Food,multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours
Other,datasets
Other,lymphNodeMetastasisInPatientsWithBreastCancer
Other,termsOfMechanism
Other,hospitalFromJanuary2016ToFebruary2017
Other,growing
Other,promisingNoninvasiveBiomarkerForDetectionOfDiseases
Other,inCanadaOfferedInOrganizedPrograms
Other,mostInvolvedSegmentsWithSuvmax39
Other,controlled
Other,731Percecnt
Skin,needForAwarenessOfMimicsOfBoneMetastasis
Other,hasRecentlyProposedAsCrucialRegulator
Other,survivalRatesOfLungCancerContinue
Other,invasive
Other,evaluated
Other,combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer
Other,importantRoles
Other,termsOfKyotoEncyclopediaOfGenes
Other,womenWithExtremelyDenseBreasts
Quantification,quantification
Other,added
Other,clinocopathologicOfPi3k/akt/ptenPathwayInMoroccanTripleNegativeBreastCancerPatients
Other,relationshipBetweenNlr
Other,theirExperiencesLivingWithSister
Other,survivalVariance
Other,trastuzumabTherapy
Other,additionalIndicator
Isolation,clinicalFeasibilityOfCtcIsolation
Other,couldPotentialBiomarker
Other,increased
Other,capecitabineRegimenAsThird-lineTreatmentForAdvancedTriple-negativeBreastCancer
Other,parameters
Other,patientSelectionForNon-pcosReferenceCohort
Other,treatmentOfTriple-negativeBreastCancerWithConventionalChemotherapeuticAgents
Other,harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio
Baseline,assessedAtBaseline
Incorporation,inStudyDevelopedByCell-selex
Other,uptakeOfTrastuzumab
Other,disrupted
Regions,sixteenRegionsOfKazakhstan
Other,moreAdvancedStagingAtDiagnosisInWomen
Other,rituximab
Other,pi3k/aktKinasePathway
Plasticity,sensitivity
Other,foxc1-knockdownBt549Cells
Other,brcanessPhenotypeInBrca1Wild-typeCells
Other,third
Other,description
Other,testingDataSet
Other,interest
Other,priorities
Other,varyingAmountsOfSolidComponents
Other,threeKinds
Other,hasFound
Other,furthermoreHaveSuggestedAsPotentialCirculatingNoninvasiveBiomarkersForEarlyDetectionOfGastricCancers
Other,immunohistochemicalTests
Other,canStressfulToPatient
Exposure,highestPerformance
Document,exponentialTiltingSemiparametricModelAccountForNonignorableMissingDataMechanism
Other,recruitmentOfOlderAdults
Other,inAdditionFurtherConfirmedInEarlyStage
Other,withandControllingForTreatmentDelays
Other,prospectivelyFollowedFor3YearsSinceDiagnosis
Interval,enhancementOfImage
Interference,itsWidespreadImplementation
Other,greaterthanorequalto10PercecntReductionInLvef
Post-diagnosis,associationBetweenPost-diagnosisLow-doseAspirinUse
Infrared,nirLight
Other,canStressful
Other,delay
Other,growthImplicatedInTumorigenesis
Other,over-represented
Other,essentialRole
Other,incidenceFactors
Other,relation
Other,colorectalTissue
Other,add-onToConventionalUltrasoundEquipmentApplicable
Mother,prominentSourceOfCancerMortalityInWomenThroughoutWorld
Other,downregulated
Other,potato
Other,whenPerformedBeforeMenopause
Other,created
Other,Stem-likeCells
Other,modeled
Other,enhancedPossibility
Other,years
Other,generalRadiologistAboutSystemicDiseases
Other,elusiveToTargetedTherapies-theTriple-negativeBreastCancer
Other,thenDefinedInReproductiveYears
Other,comparisonToCa15-3
Other,identifiablePcrResults
Other,largestCancerInformationWebsite
Other,shouldProceede
Other,terms
Other,subtyped
Other,nowAlsoWidelyUsed
Other,howeverHampered
Other,directlyAffectedByOverexpressionDownRegulationOfManyMirnas
Other,neurocognitiveSequelae
Other,RiskProtection
Hyperglycemia,highlyProblematicDose-limitingEffect
Other,shown
Other,significantConnection
Other,bayesianNetworkMeta-analysis
Other,1973To2014
Other,fiveGroups
Other,89Years
Other,frequency
Other,locallyAdvancedBreastCancer
Other,factors
Other,howeverKnown
Other,subset
Other,13PercecntOfDeaths
Other,standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting
Other,oneRandomlyAssignedToAxillaryDissection
Other,195Years
Other,highlyEffective
Other,familyMemberAffectedWithCancer
Other,willDifferent
Other,M
Other,1Year
Other,roughly15000Cases
Other,mayNecessary
Other,thriceHigher
Other,essential
Other,forefront
Other,0.32
Other,examinations
Other,IMR
Other,tumorigenesisOfBreastCancer
Other,proteinLossOfPtenByPhosphorylation
Other,largelyUnknown
Interval,postmenopausalPeriodWithDopamineAgonists
Other,typicalWoman'sDisease
Skin,pax6OverexpressionIncreasingMmp2Andmmp9ExpressionAtMrnaLevel
Endocrine,earlyDetectionOfProstateCancer
Other,up-regulated
Other,riskOfBreastCancerInAdulthood
Other,novel
Other,consultations
Other,ssessed
Document,modelAccount
Other,mostCommonCancerInWomen
Other,defined
Other,10Percecnt
Other,significantIncrease
Probe,nirProbe
Appearance,dataForAccuracy
Other,supportVectorMachine
Other,significantlyCorrelatedWithOverallSurvival
Sleep,importanceOfProactivelyAddressingFertility
Resistance,capabilitiesOfCellInvasion
Other,featured
Skin,clinicalSecondLevelExamination
Food,documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer
Functionality,functionality
Other,SCs
Resistance,bl1Cell
Other,itsRole
Other,21Months
Other,hazards
Other,7PercecntForCdx2
Other,synthesized
Interference,complication
Other,canCategorized
Other,henceMainlyBased
Contraception,20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,less-effectiveChemotherapyAgents
Other,rightMastectomyWithSentinelLymphNodeBiopsy
Other,trendForLessRadicalSurgicalApproachesInBreastCancer
Other,howeverElusive
Other,Cells
Other,her2Expression
Other,developmentOfClinicalDecisionSupportSystemsForBreastCancerDiagnosis
Other,90Percecnt
Other,6084Years
Other,tested
Other,cure
Other,alcoholConsumption
Other,invasion
Other,leftParietalRegion
Other,vap-1ImmunohistochemicalStaining
Other,itsDifficultEarlyDiagnosis
Other,others
Other,independentPrognosticFactorForDfsOfEarlyStageBreastCancer
Other,recentlyDevelopedBreastImagingTechnique
Other,serious
Other,correlation
Incorporation,associationStudy
Other,mda-mb-231Cells
Other,forWomenWithBreastCancerMayMoreFeasible
Other,treatmentOfBreastCancer
Other,aspirinUse
Other,weak
Other,brca1Wild-typeCells
Other,initiationOfPromptTherapy
Other,recruitment
Endocrine,commonEndocrineDisorder
Other,understood
Other,120Patients
Other,variousEnvironments
Other,highVolumeAcademicCenters
Provision,probablyTranscriptionalActivation
Interval,fieldOfCancerClassification
Other,couldEmployed
Other,onlySubgroupWithProgesteroneReceptor
Incorporation,ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy
Other,hampered
Obstacle,collectionOfSignsResultingFromObstructionOfSuperiorVenaCavaIncludingSwellingOfUpperBodyOfHead
Other,uterus
Other,moreoverPoor
Other,standardAxillarySurgery
Other,uniqueProperties
Other,oestrogenReceptorPositiveIn58PercecntOfCasesPositiveIn62Percecnt
Other,hasMadeInMolecularSubtypingOfBreastCancer
Other,shouldElaborated
Other,association
Other,developmentOfMetabolicDisorders
Other,breastCancerScreeningProgramme
Other,sequelae
Other,threeCases
Other,them
Interval,youngerAgeGroup
Other,confirmed
Other,canDetected
Provision,medianFollow-upOf48Years
Other,diffuseGastricCancerPresentedWithClp
Other,risk
Other,commonPlatformForStakeholdersIncludingPolicymakers
Other,warranted
Other,m
Exposure,performanceEvaluation
Other,subsequentMalignanciesForLung/bronchusCancerWith13PercecntSurvivorsSufferedFromSubsequentMalignancies
Other,successOfSymmetricPositiveDefiniteMatrices
Markers,theirRelatedMarkersAtDifferentPointsOfChemotherapyRegimensInMetastaticBreastCancer
Other,quality
Other,stratification
Other,critical
Other,objectives
Other,particularlyPatientsWithDenseBreastTissue
Other,lowIncomeCountries
Other,scrutinized
Other,cancerCareNetwork
Other,exon32OfMammalianTargetOfRapamycin
Other,5Percecnt
Other,eralphaSignalling
Other,differentClinicalOutcomes
Other,inhibited
Other,diverse
Other,hasUsed
Other,commonMedications
Other,systemicChemotherapy
Other,uptake
Other,adverseEffectsOfMtorInhibitors
Other,lessLikely
Other,obtained
Other,diverseMalignantTumors
Other,4.71
Other,records
Other,breastSurgery
Other,138Patients
Other,especiallyPost-neoadjuvantTreatment
Resistance,conflict
Other,deep-CNN
Other,addition
Quantification,successfulQuantificationOfCa15-3InSerumSamplesFromCancerPatients
Extract,highFreshLeafEthanolicExtractConcentrations
Other,comparison
Other,asianCountries
Other,about30Percecnt
Other,quantitative
Other,resectedPrimaryLungCancer
Appearance,accuracyOfLesionDetection
Other,costs
Other,annualMammographyAssociatedWithEchography
Other,mostPrevalentTumorFollowedByLow-gradeBNon-hodgkinLymphoma
Other,mostCommonNeoplasms
Other,95PercecntConfidenceIntervals
Resistance,panelOf25GenesInvolvedInMechanismsOfTargetedTreatmentResistanceIn16PrimaryBreastCancersDevelopedDuringTreatment
Other,concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer
Other,oneYear
Other,375Percecnt
Other,clinicalSettingOfPreviouslyVagueDiagnosisInImaging
Document,content
Food,heartFailureParticularly
Other,care
Other,mostFrequentCancer
Other,targetedImaging-guidedPhotothermal/chemoSynergisticTumorTherapyWithHighTherapeuticEfficacy
Other,scPhenotype
Other,shouldCo-managed
Other,mriProtocols
Other,ai-associatedSevereTendinopathy
Other,life-threatening
Extract,clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification
Other,patients'MedicalRecords
Other,observed
Other,iraqiWomenWhencomparedToWesternWorld
Other,validatedAlgorithms
Food,issue
Other,dramaticallyIncreasedAmount
Other,prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016
Other,perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer
Other,suspected
Other,canBenign
Relapse,better
Other,tests
Other,bone-modulatingAgents
Other,urgentlyNeeded
Areola,pulmonaryEverolimusSideEffects
Other,inflammatory
Resistance,activityOfTransplantedTumors
Other,furthermoreAssociated
Other,february2012InNargisDuttMemorialCancerHospital
Markers,immunohistochemicalMarkers
Other,twoSutegories
Other,surrogates
Other,tightDoctor-patientCollaboration
Appearance,goodDiagnosticAbility
Other,genesInvolved
Other,fusionProteinsWithHaloTag
Interval,after6Months'TherapySignificantlyHigherIn3rdTertiaryGroup
Other,familyMember
Other,multipleBiologicalRolesIncludingParticipationInImmunosuppressiveStudies
Other,acceptableSafetyMargins
Distance,date
Other,breastCancerPatientsWithParticularReferenceToOverallSurvivalAndrecurrenceFreeSurvivalAmongBreastCancerPatients
Other,approximately75PercecntOfBreastCancers
Other,hasAssociated
Other,dose-dependentReductionInBrca1Levels
Other,differentHistologicalAspects
Other,differentBreastCancerMolecularSubtypes
Other,unreported
Other,severalTumorSuppressorGenesInLungCancerPatients
Other,aiDiscontinuation
Other,inflammatoryBreastDiseaseWithUnknownEtiology
Other,type
Other,importantComponent
Provision,follow-upSchemes
Other,values
Obstacle,barrierFunction
Appearance,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
Other,employed
Infrared,infraredFluorescentDye
Other,applicationsOfRadiomics
Other,89FfdmCases
Other,strongIndependentPrognosticFactor
Other,haveIntroduced
Other,differentiationBetweenBreastCancerInVariousSubtypesOfBreastCancer
Other,township
Other,mostFrequentlyDiagnosedCancer
Other,hypomethylated
Incorporation,inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines
Other,inception-v3Cnn
Other,multiplexPlatform
Other,65Ng/ml
Other,potentialBiomarker
Other,validated
Other,southernPortuguese
Incorporation,inPresentStudyPerformedFor9Features
Other,novelTherapeuticBiomarkerForDiagnosis
Craniotomy,forPrecisionResectionUrgentInFieldOfDiagnosis
Other,hasValidatedDatabase
Other,implications
Other,cnvsOfDifferentCancers
Other,amplifications
Other,component
Other,platform
Other,paper
Other,standardMethod
Other,considered
Other,prevention
Other,incidenceOfCancer
Other,use
Other,bilateral
Other,correspondingCohort
Other,couldConsidered
Other,scalable
Other,therapy
Other,consequentlyPredicted
Neuropathy,possibilityOfEarlyDetectionOfRiskOfOsteoporosisToItsDevelopment
Other,january1998June2017
Other,responsible
Other,inPaperUsed
Lymphedema,developmentOfLymphedema
Other,itInvolvesInManyCrucialMetabolicProcesses
Other,widelyUsed
Other,youngerBreastCancerSurvivors
Other,threeKindsOfAlgorithms
Other,noted
Other,inadequate
Other,cancerDiagnosis
Exposure,limitedPerformanceForWomenWithDenseBreasts
Other,outpatientClinic
Other,highestRateForUpperGastrointestinalCancers
Disturbances,sleepDisturbances
Other,patients'Self-monitoring
Other,contexts
Other,91PercecntInPatientsWithBreastTumors
Other,ASSIA
Other,earlierAges
Other,ways
Other,highlightConsiderations
Other,potentialSourcesOfVariance
Other,neonatal
Extract,mostImportantCause
Other,alsoObserved
Other,limitations
Other,importantOfSpc24ForClinicalTreatment
Other,necessity
Obstacle,hazardRatiosWith95PercecntConfidenceIntervals
Other,adjuvantAnastrozole
Other,following
Document,questionnaireBasedOnAnderson'SdelayModel
Food,ourExperience
Other,outcomeOverCosts
Other,falsePositives
Other,worseOutcome
Other,significantlyAssociatedWithSeveralHealthOutcomesForTargetChild6YearsLaterIncludingCertainInfections
Other,moreDesirable
Other,noninvasive
Other,need
Other,role
Other,consistent
Other,oncogenesEsr1
Other,associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen
Other,itsImportantRoleInEtiologyOfManyDiseases
Other,featureMining
Other,survivalThanAdjuvantTherapy
Other,extremelyRare
Other,abundantlyPresent
Other,severalOtherGenes
Other,diseaseDefinedByTumor
Other,advancesInBreastCancerDiagnosis
Other,doseConcerns
Other,773Percecnt
Other,numberOfLong-termSurvivors
Interval,preliminaryGroupOfCtibl
Other,diagnosisOfAcuteCoronarySyndromes
Distance,firstYearsAfterWithdrawal
Other,evenSeveralChemotherapySessions
Other,potentiallyCurativeRegimensOfCancerChemotherapy
Other,represented
Other,old
Other,0.00001
Other,female-specific
Other,tackled
Other,prospectiveInformationAboutCharacteristicsOfWomenWithLungCancer
Other,profile
Interval,overPeriod2008-2012RegisteredInOlderAdultsInFourPopulations
Erythematous,boundErythematousAppearance
Other,poorPrognosis
Other,4Domains
Other,featureFactorsOfPrss
Other,presenceOfTendinopathy
Other,negativeIndicator
Metformin,metformin
Other,prohibitivelyExpensive
Other,patientsWithCancer
Other,proteinExpressionOfNf-krab-p65
Other,high-riskWomen
Other,screening
Other,OSs
Other,thusImportant
Other,resultCompatibleWithMetastasisToOrbit
Skin,3GroupsBasedOnTertiarySolubleSt-2Level
Other,initiationOfBreastMalignancy
Other,thusMeaningful
Other,discrete-timePartiallyObservableMarkovDecisionProcess
Collision,assessmentOfImpactOfAdvancesInDiagnosisOfPatientsWithBreastCancer
Other,mostFrequentMetastaticTumors
Food,differentContrastAgent
Other,18f-fluoro-deoxy-glucoseCombined
Other,cruciferousVegetables
Other,indicator
Food,followedFromDateOfFirstDiagnosisOfAdToEndOf2013
Food,atEndOfFollow-upClassifiedRegardingTheirAdherenceToRecommendationsForCancerPrevention
Other,recommended
Extract,average
Other,challengingProblem
Other,alsoSignificantlyLower
Other,byDevelopmentOfHybridomaTechnologyHaveProducedInManyLaboratories
Other,histologicalStructureOfTumorTissues
Other,antibodyDrugConjugates
Areola,itSideEffects
Other,autopsyStudies
Other,abnormalUterineBleeding
Users,non-nsaidUsers
Other,product
Other,familyHistoryOfDisease
Disruption,perturbation
Other,mostCases
Other,significantlyDecreased
Resistance,Cell
Other,her2Overexpressing
Other,pax8AMetastasesOfCancer
Other,182Percecnt
Other,couldDetectedByMammographyBySelf-detection
Other,5-khzFrequencies
Other,operablePatients
Resistance,cellMigration
Resistance,theirEffectsOnHumanBreastCancerMda-mb-231CellGrowthInhibition
Other,2/149
Other,canDiagnosed
Other,differentPatientRaces
Other,kaplan-meierCurves
Other,moreRecommended
Other,pre-diagnosticObesity
MSOT,MSOT
Provision,cytokineFunctionsLeadingToDevelopmentOfCancers
Markers,mightMetastaticCrcMarkers
Other,pool
Other,v-gCalciumChannelBindingAntibodies
Other,criticalRole
Other,classificationOfMammograms
Images,increasedContrast-to-noiseRatioForMonochromaticOverClinicalImagesForWell-definedPhantom
Other,MEDLINE
Other,importantForDiagnosis
Other,posteriorFossaOfBrain
Other,5T-mds/mpn
Other,pragmaticApproachToPopulation-basedCancerScreening
Other,retrospective
Other,syndromes
Other,lung/bronchusMalignancies
Other,signalTransductionMoleculesIncludingProteinKinaseC
Other,haveReported
Other,outcomes
Other,only1ulOfSerumSample
Hyperglycemia,effect
Other,algorithm
Other,generallyReserved
Other,t-MN
Other,tumorNeoangiogenesisSimilarToBreastMagneticResonanceImaging
Other,shouldEstablished
Other,formulation
Other,17Years
Other,mostPrevalentType
Other,linked
Other,made
Incorporation,inStudyDevelopedForHighlyEfficientIsolationOfCtcsFromBreastCancerPatients
Provision,base
Other,her2Status
Neuropathy,preventionOfChemotherapy-inducedNeuropathy
Other,withFourier-domainReconstruction
Late-stage,risksOfLate-stageDiagnosis
Other,typicalHormone-dependentTumor
Other,major
Resistance,drugResistanceOf
Sleep,secondDecadeAfterDiagnosis
Other,statisticallyCorrelated
Relapse,betterUnderstandingOfRisksAssociatedWithM
Sleep,currentUsersOfLongerDuration
Other,increasedRiskOfEndometrialCancer
Images,microscopicImages
Other,statusOfScreeningWomenWithDenseBreasts
Other,significantlyHigherThanInFamiliesOfNfpaPatients
Plasticity,lowDiagnosticSensitivityForWomenWithDenseBreasts
Other,isReplaced
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,survivalDifferences
Other,2007
Other,nano-biosensor
Other,theirContraceptivePreferences
Other,usuallyDiscoveredIncidentally
Other,414Percecnt
Other,evolve
Other,chemotherapy
Document,nomogram
Other,evolveTowardLessSurgery
Other,trastuzumabTherapyForBreastCancer
Other,improvedQualityOfLife
Other,groups
Other,NLR
Other,cancer-relatedDeathsAmongWomen
Other,classified
Other,dryness
Other,appropriateIntegrationOfPreprocessing
Other,roughly15000CasesPerYear
Other,differentPhotosensitizerForPhotodynamicTherapy
Other,theirOriginallyTargetedPopulationsOfBreastCancer
Other,feasible
Interval,longPeriodOfTime
Images,featuresFromImages
Food,assay
Other,breastCancerTissues
Other,cancerTreatment
Other,increase
Other,gtpaseInBreastCancerCells
Other,combination
Other,IC
Other,prognosticSignificanceOfNeutrophil-to-lymphocyteRatioInPatientsWithBreastCancer
Other,lossOf020Quality-adjustedLifeYears
Distance,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
Other,understudied
Other,negativeEffects
Other,advancedTechnologies
Other,2651StudiesIdentified
Other,pitfall
Appearance,importanceOfNondestructiveTestingInDefectStudies
Other,mightUseful
Other,variousArtifactsIntroducedDuringSlidePreparation
Other,240MonthsWith1SurvivalRateOf707PercecntRespectively
Other,questionnaireAdministeredOnJapan'sLargestCancerInformationWebsite
Other,manyWays
Other,aberrations
Other,malign
Other,tamoxifen-resistanceInErCancerCells
Other,potentialMechanismForFoxc1-inducedMetastasis
Other,itsReceptorLocatedInManyCellsOfBody
Interval,highestSeInTotalGroup
Other,devastatingDiagnosis
Other,switched
Other,growingProblem
Other,significantlyHigherPcrRatesThanPatientsWithLuminalTypes
Other,phosphatase
Resistance,bl1CellMda-mb-468
Other,dominantArms
Other,usd$901
Other,useful
Other,breastCancerSubtypesa
Other,acquisition
Infrared,mildUvLight
Other,amongYoungerPeopleCommon
Other,earlyStageDiagnosisOfTumors
Other,urgent
Other,youngWomenWithInvasiveLobularCarcinoma
Other,attention
Other,27PerCentOfPatients
Other,SRS
Other,G
Other,invitedInputFromExpertsInSpecificAreas
Extract,averageOfFiveInvolvedSites
Incorporation,includedInStudy
Other,Barshi
Other,breastCancerAged
Other,histopathologicFeatures
Other,common
Other,firmlyPlaceWithRecentTrendsTowardDecreasedRatesOfRe-excision
Distance,sinceItsFirstDescriptionAtInstituteOfPathologyInKielAgoHasShown
Other,oncogenes
Other,patientsWithMeasurementErrors
Other,well-established
Other,willUsed
Other,riskOfBreastCancer
Other,mostCommonCancer
Other,referenceForClinicians
Other,revealed
Collision,collisionTumorWithBreastCancerMetastasis
Other,significantCausativeGenes
Provision,60ControlPatients
Other,inflammatoryDiseases
Other,populations
Other,cancerSignaling
Other,putativeBiomarkerForDetectionOfVariousHumanDiseases
Other,project
Areola,severeSideEffects
Other,patientsWithLocoregionalInSouthernPortuguese
Relapse,exit
Collision,typeOfCollisionTumor
Other,multivariateModelsAdjustedForIncome
Other,moreoverStronglyRecommended
Other,treatmentWithWholeBrainRadiotherapy
Interval,meanwhileBetterThanInCapecitabineGroup
Other,humanBreastNeoplasmsWithDeregulationOfSeveralMirnas
Other,functionalizationStepsForRapidDetection
Other,93Percecnt
Other,riskOfDevelopmentOfGliomas
Other,processing
Other,levels
Other,presented
Other,this
Other,diverseBiologicalProcesses
Obstacle,block
Other,organotropic
Other,hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma
Other,neededAcrossCareContinuumEspeciallyInLow-resourceSettings
Other,lessEffective
Other,classic
Other,covariates
Other,positiveRegulatoryFeedbackLoopForFxyd3Amplification
Behaviours,theirHealthBehaviours
Other,mostCommonlyDue
Other,routineProcedure
Other,poor
Other,prognosesOfYoungMenWithBreastCancer
Other,twoMoieties
Other,metastaticDisease
Skin,bone
Other,taiwanLongitudinalHealthInsuranceDatabase2005
Other,likelyParaneoplastic
Other,mostSensitiveTest
Other,whenGiven
Dysplasia,regression
Other,collected
Other,only44Percecnt
Other,near-infraredLight-controllable
Other,mayUsedForTumourShrinkagePriorToSurgery
Other,shouldConsideredInEventOfAbnormalImagingFindings
Other,adjustingForPotentiallyConfoundingFactors
Other,pre
Other,thematicAnalysis
Other,target
Other,57PercecntOfPatients
Other,73-yearOldWomanPresentingWithLeftBreastLumpClinicallyIndeterminate
Other,thenShouldTestedForSpecificGeneMutationFound
Other,selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
Other,suvmax39
Other,breastCancerCells
Other,stillDifficult
Other,fused
Other,areaOfResidence
Other,moreEffectiveTreatmentOfLungCancers
Other,variables
Other,5Μl
Other,femaleBreastCancerMortality
Other,intopreGroups
Other,mainlyExpressed
Other,important
Other,tissueStorageTime
Other,high
Other,conservativeTreatment
Other,opportunities
Other,mean
Other,needsOfInformationSeekers
Other,humanBody
Other,48Years
Other,greaterthanorequalto1Lineage
Other,neonatalOfRetrospectiveCohortOfPregnantWomenWith
Other,registered
Other,healthExpectancyOfItspopulation
Interval,g1/s-phaseCellCycleArrest
Interference,preoperativeAssessment
Other,promisingShort-termStrategiesPriorToTreatmentAdministration
Other,potentialForOverdiagnosis
Other,breastCancerInAdultsInChildren
Interval,interval
Other,willLeadToMortalityReductionsWithoutUsualScreeningHarms
Other,analysisOfLncrnaExpressionProfiles
Extract,complementaryBenefit
Other,oestrogenReceptorCofactors
Endocrine,hormoneReceptor-positiveTumors
Other,alsoAssessedByQrt-pcr
Other,radiation
Other,subtype-specificPrognosticSignatures
Other,detectionOfBreastCancerInWomen
Other,including
Other,retrospectiveStudies
Other,mostCommonAdultCancersInKenya
Other,denseBreasts
Sleep,youngerAge
Other,mir-511Expression
Other,arms
Other,hasApplied
Other,unusual
Stigmatization,sexualStigmatizationOfM
Other,widelyUtilized
Other,computedTomographyOfBrain
Other,dataOn108Pb-dllPatientsFrom21ChineseMedicalCenters
Other,aboveConditions
Relapse,riskOfBreastRelapse
Other,utility
Other,roleForPre-existingInborn-likeErrorsOfMetabolism
Other,disadvantages
Other,hasMade
Other,ideallyPlaced
Other,developmentOfSubsequentLung/bronchusCancer
Appearance,surgicalAccuracy
Other,importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation
Other,alsoUsed
Other,robustTechnology
Interference,theirBeliefsRegardingCancerCausation
Other,RL
Skin,levelExamination
Other,differences
Skin,mrnaExpressionLevelOfPcdh10
Other,cytotoxicActivitiesOnMcf7
Other,uniqueFeatureInteractWithNucleicAcids
Other,fundamentalComponents
Other,mir-193b-3pBinding
Provision,breastCancerControlEfforts
Other,haveBackbone
Hyperglycemia,cell-killingEffectInTriple-negativeSubtypeMda-mb-231Cells
Other,mammography
Other,relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer
Other,upregulated
Other,associatedWithBreastCancerRisk
Other,extensiveAttentionOfResearchers
Other,minimalRedundancyMaximalRelevanceAlgorithmAsFeatureSelectionMethods
Other,practicePatterns
Other,kaplanMeierCurves
Other,expressionOfChemokineReceptor-4
Other,her2-positiveEarlyPatients
Other,1984
Other,potentialTarget
Other,PM
Other,protectiveFactors
Endocrine,termsOfProlactinNormalizationInPituitaryFunction
Other,phosphorylationOfAkt
Other,scEnrichment
Other,needed
Other,member
Other,immunocaptureOfMarker
Other,tumorSuppressorMir-10aInCells
Other,phosphorylation
Other,strategy
Other,expressionOfOtherBiomarkers
Other,highBurdenOfCancer
Other,417Percecnt
Other,72Months
Other,BMI
Food,kernelApproach
Other,localEntropyMaximizationAlgorithm
Other,discussed
Markers,specificMethylationMarkersImportantForCrcDetection
Sleep,stillSeriousHealthProblemIn21stCenturySubjectToManyResearch
Other,thirdInTermsOfSpecificMortality
Other,moreInclined
Other,hasSuggested
Other,clinico-pathologicalFeaturesOfMetastases
Other,subsequentPrimaries
Behaviours,healthBehaviours
Other,featureSelection
Interval,periodFromApril2012ToDecember2017
Other,oneExtraVisit
Membrane,atrophiedVaginalMucosa
Other,hasUsedInLeukemia
Resistance,shouldOvercomeBeforeClinicalApplication
Other,hasRecentlyDeveloped
Other,secretion
Exposure,discovery
Probe,fluorescenceMicroscopy
Collision,impactOfStableKnockdownOfSmarcad1OnHumanBreastCancerCellProgression
Other,trueRisk
Other,substantialDelayFromDiagnosisToTreatment
Plasticity,976PercecntSensitivity
Food,potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
Document,improvedDiagnosticContentOverEx-vivoClinicalMammographyImagesAtLowerDose
Other,shouldStaged
Other,theirCare
Interval,groupProfilesForSubgroup
Other,tomography
Other,queried
Other,5-Fluorouraci
Other,challenges
Other,type1Diabetes
Provision,leadingCancerSitesInOlderMales
Other,roleOfEstrogens
Other,quantified
Appearance,inConclusionPathogenicFeatureInPrimarySamples
Other,independentPrognosticFactor
Pediatric,accurateDiagnosisInPediatricPatients
Other,non-ideal
Plasticity,bodyMassIndex
Other,mortalityRate
Other,correctionMethod
Other,contralateralBreast
Other,histopathologicallyProvedBreastTumors
Relapse,betterOs
Other,presentation
Other,mostPrevalentMalignancyAmongWomenAroundWorldAreDiagnosedYear
Skin,contextOfTwoCasesOfBladder
Other,solidTumors
Other,ssessedByWoundHealingAssayinAddition
Other,importantComponentOfMitoticCheckpointMachineryHaveShownInSeveralCancersIncludingAnaplasticThyroidCancer
Other,motivated
Other,roles
Document,zebrafishTumorModel
Other,62Years
Other,determined
Other,pharmacokineticProperties
Other,especiallyFrequentLateRelapsesInCnsBreast
Other,breastCancerConfinedWithinMammaryDuctsSurrounded
Other,specialEmphasisOnTheirDifferentialDiagnosis
Other,locoregionalDiseaseOfUnspecifiedLocation
Plasticity,sensitivityAnalysesresults
Other,reportedInSignificantlyHigherProportionOfPatientsWithPa
Other,confounders
Other,effective
Other,pathogenic
Other,5-yearResultsOfPhase3Isg23-01Trial
Other,inconsistentResults
Other,appropriateAllocationOfResearchFunding
Relapse,mitoticExitOfPtx-pretreatedCells
Other,variability
Other,anticipated
Other,needsInPrevention
Other,retrieved
Interference,rareComplicationMostCommonlySeenInPatientsPreviouslyTreatedForBreastCancer
Other,components
Other,surveillancePopulation-basedData
Other,howeverWidelyUnderstood
Other,nationalTrials
Other,consistentMass-spectralData
Incorporation,experimentalStudyOfCryo-stabilityOfCancerCells
Other,dopamineAgonist
Other,manifold
Endocrine,hormoneReceptor-positiveBreastCancer
Other,imagingFeatures
Other,routineUseByFoodAdministrationIn2002
Other,pregnancyOutcomes
Other,patientsWithNeoplasticDisease
HER-2,adultsWithHer-2PositiveBreastCancer
Other,expressions
Other,westernBlotAnalysis
Other,evidence-basedDecision-makingForPopulation
Other,sentinelNodeBiopsy
Extract,benefit
Other,significantlyReduced
Other,otherSites
Other,risksOfCancerInMutationsCarriers
Other,cancerCounseling
Other,prognosticFactorsOfCancerProgression
Other,pattern
Other,SpCM
Other,itsPoorPrognosis
Other,unknown
Other,evenSubgroupOfPatientsTreatedWithRituximab
Other,advancedDiagnosticImaging
Resistance,cellInvasion
Applicability,applicability
Other,severeThreat
Exposure,reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes
Other,complexKaryotypes
DNA,dnaMethylationDifferencesBetweenTumorBreastTissue
Other,significantlyYounger
Other,anti-apoptoticEffectsOfEstradiol
Document,associationBetweenNsaidsExposureInFemalePatientsWithAd
Markers,diagnosticValueOfMarkers
Document,balfContentOfProgranulinIn46NsclcPatientsBeforeChemotherapy
Other,estrogen-aloneArmOfWhi
Other,Kazakhstan
Other,mostPowerfulTool
Other,greaterthan1500Pg/ml
Other,associatedWithPfsAlthoughAtExtent
Other,balb/cNudeMiceBearing
Other,analyzed
Probe,novelNear-infraredNirFluorescentProbe
Lifestyle,responseFollowingAdministrationOfNeoadjuvantChemotherapy
Other,portugueseWomen
Other,thereforeCentralTarget
Other,nsclcPatientsAssociatedWithShorterOverallSurvival
Other,size
Other,mostCommonMalignantTumor
Other,related
Other,multipleMitochondrialMetabolicPathways
Other,forRace/colorVariableEstimatedWithAdjustmentForStatus
Other,manyResearchers
Other,acid
Other,expressionOfMir-511InBreastCancer
Collision,theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors
Other,humanErrors
Other,cross-sectionalCategories
Other,patientsFrom10Countries
Other,brca1Wild-typeTripleNegativeBreastCancer
Other,moreAdvancedStages
Other,associationsBetweenAspectsOfDiet
Other,improvement
Other,breastCancerPatients
Other,utilization
Other,included.When
Other,allow
Other,frequentlyDetected
Other,routine
Other,dissectionOfLymphNodes
Neuropathy,irregularHyperintenseLesionInT2InLeftParietalRegion
Macroadenomas,usuallyMacroadenomas
Provision,moreIntensiveFollow-up
Other,biologicallyDifferentDisease
Interval,key
Other,-69PercecntTo+239Percecnt
Other,leastAbsoluteShrinkage
Other,asResultAreUsed
Other,localizedDescriptionOfBreastCancer
Other,assessments
Other,rapidBreast-cancer-tissueDiagnosis
Other,breastCancerTherapy
Other,patients'MedicalRecordsFromOctober2007ToDecember2012
Other,redoxStatus
Other,determinationOfUnderlyingBiologyWithinTumors
Other,mostPrevalentCancer
Other,recurrence
Appearance,variedDegreesOfStructuralComplexity
Distance,breastImageneologicalSurveillanceBeginningAtAge
Other,brd4Regulation
Other,world
Other,segments
Other,tumorSamples
Other,shanxiProvinceOfChina
Other,achievedForHer2Status
Other,selectPatientPopulations
Other,status
Other,women'sCancerAccounting
Other,physicallyActive
Other,49CedmCasesCollectedFromMayoClinic
Other,knowledgeGaps
Resistance,panelOfCellLinesWithDifferentPhenotypes
Other,furthermoreRestricted
Dysplasia,penalizedLogisticRegression
Other,studied
Other,differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
Other,isIdentified
Other,diet
Other,humanBreastCancerCells
Other,diagnosisOfBreastCancer
Other,report
Other,howeverUnderutilized
Other,formed
Other,designedByDivisionForBreastCancerOfKoreanRadiationOncologyGroup
Other,future
Other,prognostic
Resistance,resistance
Other,0.0001
Skin,skinOriginatingFromInternalCancer
Other,subsequentMalignancies
Other,emergingPublicHealthProblemInLowCountries
Other,12EventsAmong121Patients
Other,theirOwnParticularity
Resistance,choiceOfImmunohistochemicalTechniques
Other,methods
Other,decision-making
Other,nanoparticels
Other,subsequentCancerCounselingOfFemaleSurvivors
Other,used
Other,prevalenceOfobesityOf277Percecnt
Other,visualizedTheranosticsOfTumors
Other,therapeuticTargetForPotentialTreatment
Other,howeverShouldPerformed
Other,grafts
Other,lower
Collision,injury
Other,potentialBiomarkerForCancerDiagnosisThanMrnaBiomarkers
Other,hasProposed
Hyperglycemia,effectOfDdtSpraysOnBreastCancerIncidenceRate
Other,tumorGrowth
Other,reference
Other,neglected
Other,commonFeature
Craniotomy,excision
Other,moreRefinedStratificationThanAnatomicStageAlone
Modulators,associationBetweenUseOfSelectiveEstrogenReceptorModulators
Other,nationwideRegistries
Other,unclear
Other,strong
Other,importantContributors
Other,criticalRoles
Other,inductionOfFamily
Other,cnvData
Other,value
Other,currentTherapiesAvailable
Other,strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen
Other,TIVAP
Appearance,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,byMultivariateAnalysisSignificantIndependentPrognosticFactorOfOs
Other,244GermlinePathogenicVariants
Other,geneticPredispositionForCancer
Glycosylation,glycosylationOfMembraneTypeMr
Other,effects
Other,seen
Provision,pathologyForFurtherFollow-up
Other,highlyExpressed
Other,otherImagingCharacteristics
Other,moreEasilyHypomethylated
Hyperglycemia,effectOfBaicalinInBreastCancer
Other,bilateralBreastLumps
Other,breastCancerTissueMicroarrayWithAccessToReceptorAnalyses
Other,3Malignancies
Other,2IndependentCohorts
Other,32620MatchedPatientsWithoutPcos
Other,11BreastRadiologists
Hyperglycemia,effectOnBoneRemodelingThroughItsReceptor
Other,couldSutegorizedIntoT2aWithCutoffValueOf3Cm
Other,popular
Other,cells
Other,healthInitiative
Other,survivalTime
Other,attentionToSpecialGroups
Other,aimed
Other,greatBenefitsAgainstBreastCancer
Other,recursiveFeatureElimination
Other,higherRisks
Resistance,consistentWithBreastCancerCellResultsSignificantlyInhibited
Sleep,ageOf25Years
Skin,significanceLevel
Other,notablyDesigned
Collision,theyCanImpactOnQualityOfLifePresent
Mastectomies,mastectomies
Other,variousImportantFunctions
Other,thatOfMir-511
Other,abstractDataOnTheirClinicalCharacteristics
Other,associated
Other,medicalHistory
Other,riskStratification
Incorporation,third-lineTreatmentForAdvancedTriple-negativeBreastCancerthisRetrospectiveStudy
Other,optimalTherapeuticTargetForPatientWithAdvancedBreastCancer
Other,mostRelevantKind
Other,481Women
Other,followed
Other,type160Patients
Other,developmentOfManyMetabolicDisorders
Resistance,suppressionOfCellSurvival
Other,Development
Other,hasFocusedOnTumourCellsPrimarily
Dysplasia,coxRegressionAnalyses
Other,mostlyBilateral
Other,currentEvidenceOnEfficacyOfHer2-targetedTherapiesInOlderAdultsWith
Interval,highlyDiverseGroupOfMalignantNeoplasiaWithPoorOutcome
Other,improvedPatientOutcomes
Provision,effectsOfAnnexinA3OnBreastCancerBiologicalBehaviorInVivo
Other,well-establishedTreatment
Other,10Countries
Other,mda-mb-231CellsMeasuredBy3
Autoantibodies,roleOfAutoantibodiesInEarlyCancerDiagnosis
Other,potentialMechanism
Other,markedlyDownregulated
Other,higherProportion
Other,breastTumorigenesis
Appearance,diagnosisAccuracy
Other,inexpensive
Other,typical
Other,13
Other,eventHybridizationOfMirna-21Biomarker
Other,haveAssociated
Other,napsinAIn7Percecnt
Other,cytotoxic
Other,younger
Other,balfOfNsclcPatients
Other,mostPrevalentMalignancyDiagnosedInPregnancy
Resistance,capacityForEarlyDiagnosisOfBreastCancer
Resistance,panelOfMonoclonalAntibodiesAgainstNewlyEstablishedCellLine
Collision,mostFrequentlyDiagnosedTumorInWomenWorldwideWithSignificantImpactOnMorbidity
Extract,commonCauseOfMorbidity
Provision,leadingCauseOfMorbidityWorldwideYetMethodsForEarlyDetection
Other,canEasilyExtended
Other,planning
Other,implemented
Other,water
Other,10NeedContents
Endocrine,prostateCancerSurvivors
Other,efficientSignaturesForClinicalDiagnosis
Other,malignantProgressionOfBreastCancer
Exosomes,problemOfDiscriminationOfExosomes
Other,severe
Other,complex
Polymorphisms,occurrenceOfPolymorphisms
Other,otherTwoGroups
Other,heterogeneousPopulationsOfCellsWithHierarchicalOrganizationDrivenByCancerStemCells
Other,CMIA
Other,adherenceToEhtAmongBreastCancerPatients
Other,broadcasted
Exposure,goodDiagnosticPerformance
Other,crucial
Other,couldIndependentPrognosticBiomarkerForMPatients'Outcomes
Other,earlyStage
Other,concernForExistenceOfCancerCellsInGrafts
Other,breastCancerBrainMetastases
Other,thenExploredByRocheCobasE601
Other,mostToxic
Other,environmentalFactors
Other,understanding
Other,problem
Other,ODV
Other,anti-oncogenicRegulationOfMir-34s
Other,microadenomasDataOnLong-termRemissionRate
Other,expectedInverseCorrelationOfSerumDdtsWithBmi
Other,significantlyLower
Other,potentialTreatmentStrategyForEndocrine-resistantBreastCancers
Food,expressionOfItsTargetProteinCytokine-inducedApoptosisInhibitor1
Other,training
Food,impairedBaselineCardiacFunctionExperience
Exosomes,exosomesOf5-fu-resistantCrcCellsInThoseOfHighMetastaticCrcCells
Other,clinicalTrials
Other,enrolled
Other,significantAssociationBetweenRs5743810AllelicFrequency
Provision,rangingFromDiagnosisPhaseToControlOfDisease
Other,riskForRecurrence
Images,virtualRecombinedImagesFromLeImages
Other,intralaboratoryValidationSet
Other,earlyBiomarkersOfBreastCancerRisk
Other,importantAspect
Other,promisingNon-invasiveReal-timeSurrogatesForCancerDiagnosis
Extract,mostProminentCause
Appearance,inNumericalSimulationsAccuratelyReconstructedWith90PercecntAccuracyUpToNoiseLevelOf50Percecnt
Other,medicalDiagnosisOfBreastCancer
Other,earlyBreastCancerDiagnosisOfBreastCancerRisk
Other,improvementInClassificationOfMalignantLesions
Other,developmentOfBreastCancer
Other,etiologyOfManyDiseases
Other,clinicalVisits
Other,cardiotoxicRisk
Other,sensitive
Other,cancerSurvivors
Other,0.011
Other,overnight
Other,positiveHer2Expression
Other,familialCancerClusteringInPatientsWithProlactinoma
Other,twoCases
Incorporation,associationsBetweenChangeOfPerceivedWorkAbility
Other,2-3Years
Other,properFunctioningOfSkeletalSystem
Other,cross-sectionalStudies
Other,onlyIndicative
Other,detectedThroughScreeningThroughSigns
Other,search
Other,50
Erythematous,characterizedByAcuteAppearanceWithErythematousPlaqueSometimesHotMoreOftenSituatedInPrimaryTumorVicinity
Other,class
Other,10Centers
Other,review
Other,positivelyAssociated
Other,minimalRisksToNormalCells
Other,small
Other,canDetectedInBodyFluidsIncludingSerum/plasmaSamples
Other,breastCancerRisk
Other,futureDirections
Other,moreoverSignificantlyLower
Other,differentPhenotypes
Other,benign
Other,placed
Other,previousStudies
Other,differentiallyModulated
Other,determinantsOfCancer
Other,overviewOfAbbreviatedBreastMriProtocols
Other,GTPase
Mother,absorptionImagesAcquiredWithMonochromaticX-raysFromCompactSynchrotronSourceBasedOnInverseComptonScattering
Other,importantCopingResource
Other,closelyAssociated
Other,life
Lifestyle,oxphosTranscriptionalResponse
Other,isReplacedWithRadiotherapyInSituations
Other,timingOfChemotherapyForBreastCancersWithDifferentMolecularBackgrounds
Other,mappedToPatientPathway
Other,depicted
Other,population-basedStudies
Other,importantPhenotypicFeatureOfCdh1GermlineMutationCarriers
Other,thusPresented
Other,variableMolecularMechanismsOfCarcinogenesis
Other,biomarkers
Other,healthCareSector
Other,specificCancerCell-relatedComponents
Other,improvedDiagnostics
Other,targeted
Other,90PercecntOfPatients
Other,blackWomen
Other,fiveDoses
Other,hypothesis
Other,shouldAnalyzed
Other,recentlyHaveUsedAsBiomarkers
Glycosylation,sixGlycosylationSites
Other,binding
Distance,firstDataOnPre-diagnosisConcentrationsOfSrankl
Other,complexSemisolidMassesWithVaryingAmountsOfSolidComponents
Other,CIAPIN1
Other,required
Other,analysed
Other,neoadjuvantChemotherapy
Other,associationWithImagingOfIgm
Other,only20Percecnt
Post-diagnosis,associationBetweenPost-diagnosisUseOfLow-doseAspirin
Other,correctDiagnosis
Other,cancerManagement
Other,due
Other,overview
Other,pairedTumor
Other,oncogene
Other,trends
Sleep,stratifyingForAge
Other,mutationsCarriers
Other,post-menopausalWomen
Other,hasEstablished
Other,included
Other,specificSubtype
Other,hasIncorporatedIntoClinicalPracticeForOver100YearsAtLowCost
Other,expressionOf6CirculatingMirnasInOperablePatients
Other,lessBleedingThanTraditionalVenousThromboembolismInGeneralPopulation
Other,AS
Other,whereDeveloped
Other,conducted
Other,canIncludedInDifferentialDiagnosisOfMasses
Distance,firstTimeIn1984
Other,general
Other,pathogenicVariantsInBrca1/2
Provision,evenMorePersonalizedFollow-upSchedules
Other,investigated
Other,polymorphism
Incorporation,ronInternalization
Other,significantlyAssociated
Other,erCscs
Other,whereFacilitatedBySurfaceModificationOfNps
Other,analysis
Other,proliferation
Probe,intravenousAdministrationOfOsteopontin-750Probe
Other,patient'sOutcomeOverCosts
Other,osteopontinPeptide
Quantification,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
Other,ages
Other,chapter
Other,CTCs
Other,understandingOfEmergingConceptsOfTumorBiology
Other,determine
Provision,medianFollow-upOf9·
Other,ukCancerIncidence
Other,information
Other,earlyDiagnosis
Other,survivalPrediction
Incorporation,retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer
Other,canIncluded
Relapse,betterPrognosis
Other,missed
Other,webOfSciencePsycinfo
Appearance,receiverOperatingCharacteristic
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Other,youngMexicanWomen
Other,characteristicsOfHighDimensions
Other,thenUsed
Other,histopathologicalExamination
Other,feature
Other,clarify
Interference,disposition
Other,test
Document,detectionRateOfMutationsHigherThanThatDescribedInLiterature
Other,netherlandsCancerRegistryOf37230PatientsWithEarlyBreastCancer
Other,PI3K/AKT/mTOR
Other,secondaryLymphoidTissueDevelopmentOfLymphocytesWithinMicrocompartmentsOfTissue
Relapse,betterOutcomes
Other,preclinicalModels
Other,mostFrequentMalignancy
Other,lungCancerInHuman
Interval,totalGroup
Other,significantlyUp-regulated
Other,postmenopausalWomenWithDevelopmentOfBreastCancer
Other,Anemia
Other,singleSmallIncision
Other,recentYears
Other,q12X
Other,illiterate
Other,theirVariousness
Other,secretionOfTumorNecrosisFactor
Other,evaluatedInVivo
Other,insufficient
Other,dependentOnRigorousPathologicEvaluationOnAdministrationOfTreatmentDictatedByTumorBiology
Other,cancerSurvival
Other,643Percecnt
Other,disease
Other,845Percecnt
Other,performedFromInceptionToJanuary312018
Other,mainlyEurope
Other,applied
Other,reverseActiveLearningForClassificationOfHealthyBreastTissue
Other,trialsOfHer2-targetedTherapiesIn
Other,only35Cases
Other,alreadyWell-established
Other,identified
Other,canClassifiedAsSoluble-proteinBasedImmunocytochemical
Other,promisingBiomarkers
Pediatric,shouldPerformedInPediatricPatients
Other,fewPercentOfWomen
Other,westernizedCountries
Other,peopleWithDiagnosisOfCancer
Other,skeleton
Images,images
Other,CRD42016048917
Other,has-miR-3158-3p
Other,broadUseToPatients
Other,noninvasiveImagingTechniqueForBreastCancerDiagnosis
Other,patientsWithHer2
Extract,mostFrequentCause
Other,decades
Issues,issues
Other,twoYears
Other,now89Years
Other,distributions
Provision,activationOfOther
Resistance,moreImportantlyCanNowComplementedByEmergingDeepLearningTechniquesForFurtherProcessAutomation
Other,clinicalDiagnosticPathways
Other,howeverStillUnclear
HER-2,caseOfWomanOnNeratinibForHer-2PositiveInfiltratingDuctalCarcinoma
Other,tissueBiopsy
Other,markedlyUp-regulated
Distance,haveReportedForFirstTimeInCaninesInStudy
Other,riskFactor
Obstacle,obstacle
Other,fourSelectedPopulation-basedCancerRegistries
Resistance,cancer-relatedEventsIncludingTumorCellMigration
Other,moreoverAssociated
Document,form
Other,resistant
Other,willTested
Other,show
Other,patientsWithBreastCancer
Other,largestReviewOnPrsInAsianPopulation
Other,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,solved
Other,13Percecnt
Other,inverselyCorrelated
Lifestyle,diagnosisOfResponseToTreatment
Other,FPs
Other,tumor-bearingMiceOfMcf-7BreastCancerCells
Other,65Ng/mlForProgranulinFor-1
Other,MCC
Other,particular
Other,vap-1Staining
Extract,womenOfAverageRiskWithDenseBreasts
Other,migrationAbilitiesOfCervicalCancerCells
Other,cancer-relatedDeathInChineseWomen
Other,efficientlySynthesized
Other,findingsFromStudies
Other,poorerPrognosisInPatients
Other,comparedToThoseWithPregestationalBreastCancer
Other,contrast
Resistance,proliferationOfThreeCancerCellLinesWithLowIc
Lymphedema,unilateralBreastCancer-relatedLymphedema
Other,maySteps
Document,literature
Other,onEsophagogastroduodenoscopyIdentifiedInAntrum
Other,importantIntercellularSignalingRegulatorWithExpressionCorrelation
Other,suchLowIncidence
Other,inTotalMatchedToCasesOnBirthYear
Other,cancerMolecularDiagnosis
Other,whenSuspected
Other,genesCodingForTumorSuppressorProteins
Other,familyOfNoncodingRnas
Other,adverseEventsExceptDegreeI-iiBleeding
Other,subsequentlyAssessed
Other,management
Other,occurrenceOfTumors
Provision,thusInRecentYearsDemand
Other,empiricalTreatmentsBasedOnClinical-pathologicalCharacteristicsToUseOfTargetedApproaches
Other,january1990
Other,cancerCareSystems
Other,strongContrastWithImagingModalities
Collision,impact
Other,treated
Markers,adequateSampleForAnalysisOfMolecularMarkersToGuidePatientsWithNon-smallCellLungCancerToAppropriateTargetedTherapies
Other,predominantlyCystic
Interference,pre-operativeAssessment
Other,policyActions
Other,drawbacks
Other,potentialTherapeuticTarget
Lifestyle,influenceOfLifestyleFactorsOnPrognosis
Other,typicallyBilateral
Document,mouseModel
Relapse,withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated
Other,moreoverMostOfTimeBenignRequired
Other,femalePatientsWithAd
Other,urgentClinicalProblem
Interval,excellentPerformanceInFieldOfMedicalImagesDiagnosis
Other,0.02
Other,detectionOfMicrocalcificationInMammograms
Other,lessVisits
Other,highMortalityRateForFemales
Other,brca-associatedCancers
Other,hasPutOnIntrinsicSubtypingBasedInPresenceOfClassicalImmunohistochemistry
Other,projected
Other,mostOfPatientsDuringMammography
Other,clinicalBreastExaminationCoupledAsPrimaryTool
Other,couldDetected
DNA,involvedInDnaDamageRegulation
Other,mostPervasiveTypeOfCancerAmongWomen
Nanoplatform,skeletonOfNanoplatform
Other,thereforeCriticalSignificance
Other,pcdh10GenePromoterMethylationIdentifiedInDuctalCarcinoma
Other,prognosticSignificanceOfNlrInEarlyStage
Other,formationOfCircularizedRna
Other,diffuse
Other,approved
Other,876Percecnt
Other,bt549Cells
Other,therapeuticallyEffective
Other,theirLimitedAccess
Other,highlightImportantConsiderations
Other,automaticIntraoperativeIdentificationOfBreastCancerMargins
Other,colon
Other,example
Complications,riskFactorsForLateComplicationsAssociatedWithTivapthere
Other,result
Other,greatPotentialInDiagnosisTherapyOfCancers
Other,mir-193b-3pIdentifiedAsRegulator
Other,summarised
Drugs,developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer
Other,remodeled
Other,present
Extract,averageOf425±496Ctcs/2Ml
Other,borders
Other,preciseToolForTargetedTreatmentOfCancerIncluding
Pediatric,pediatricPatients
Other,
Other,fiveDosesOfAdjuvantTranstuzumab
Other,cancerProgression
Other,howeverHaveClarified
Other,function
Other,hasAchieved
Other,indicated
Other,prognosis
Other,contrastAfterInjection
Other,saudiArabianWomen
Other,x-rayMammography
Other,hoechstStaining
Other,EMT
Other,thusPotentialTherapeuticTarget
Other,gender
Other,allCloselyAssociatedWithPttTherapeuticEfficacy
Other,sites
Other,preparedRespectively
Other,realStatusOfPrs
Other,access
Endocrine,pituitaryFunction
Other,threeOverallSurvival
Other,earlyDiagnosisOfCancerPatients
Other,replaced
Interval,intervalBetweenDiagnosis
Other,obtainedFrom66FemalePatientsWithMAtDifferentTimeIntervalsForEvaluationOfCtcsByFlowCytometry
Other,breastCancerMcf-7
Other,methodologyOfInstitutoDeEvaluaciónTecnológicaEnSalud
Other,dependent
Other,pcosGroups
Other,ratio
Other,flowCytometry
Other,clinicalBreastExamination
Endocrine,antihormonalTherapyForHormoneReceptor-positiveBreastCancer
Other,haveSuggested
Other,menopause
Other,moreTargetedAdjuvantTreatments
Other,appropriateQuality
Other,insights
Other,comparingWithCurrentStandardMethodOfSubjectiveVisualEstimation
Modulators,selectiveEstrogenReceptorModulators
Other,46NsclcPatientsBeforeChemotherapy
Other,investigatedOnly
Post-diagnosis,time-varyingPost-diagnosisLow-doseAspirinUse
Other,resources
Other,investigate
Other,cancerCells
Other,hazardsOfBleeding
Interval,axillaryClearance
Other,stageIiiBreastCaner
Other,evidenceOffer
Other,un-recognized
Food,differencesInAssayPerformance
Other,Chi
Other,onlyIndicated
Microenvironment,fundamentalComponentsOfTumorMicroenvironment
Appearance,orderOfAppearanceFrequency
Other,DPV
Resistance,choiceOfChemotherapyInBrca-associatedCancers
Other,120BreastCancerPatients
Food,toEndDevelopedWithDrugToAntibodyRatioOf329
Other,cystic
Food,ourExperienceOfHigh-doseRadiotherapy
Other,automatedAnalysisOfClinicallyRelevantHistopathologicFeature
Collision,potentialImpact
Other,proposedHowever
Other,7Percecnt
Other,lowCountries
Other,stageIi
Other,method
Resistance,application
Other,incidenceRates
Other,advantage
Incorporation,amongThemNewlyIdentifiedInStudy
Other,greater
Other,accomplished
Other,associationBetweenRace/colorInWomenWithBreastCancer
Other,biopsy
Endocrine,treatmentOfHormoneReceptor-positiveBreastCancer
Other,highlyPenetrantGenes
Provision,activation
Other,taken
Other,diagnostics
Other,relationshipBetweenStromalExpressionOfPodoplaninInInvasiveBreastCarcinoma
Other,predicted
Other,bevacizumab-relatedCardiotoxicity
Other,differentiation
Other,hasIncorporated
Other,mostSensitiveTestForBreastCancerDetection
Other,breastCancerGrading
Other,youngWomen
Interval,fieldOfMedicalImagesDiagnosis
Other,developed
Resistance,characteristicsLikeCapacityForInvasion
Incorporation,case-controlAssociationStudyForVariantsInCodingRegionsOf11HereditaryBreastCancerGenesIn7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Other,nature
Sleep,hadDiagnosedWithBreastCancerAtEarlyAge
Other,diagnosticChallenge
Other,soFarHasMainlyAssociatedWithMutationsInBrca1
Other,cancerCare
Incorporation,chicagoStudy
Other,pathways
Other,richSpectralFeaturesOfPhenyboronicAcid-basedNanoprobe
Other,unitedKingdom
Other,complexDueToPotentialFoetalRisksInSettingOfMaternalTreatment
Other,actSynergisticallyWithPaclitaxel
Other,annexinV-fluoresceinIsothiocyanate/propidiumIodide
Other,reproducingKernelHilbertSpace
Resistance,applicationOfPhase-sensitiveTechniques
Other,significantlyCorrelated
Other,10-yearBreastCancerSurvival
Other,different
Endocrine,imagingOfProstate
Other,randomlyDivided
Other,clinicians
Other,determinantGenes
Other,indicative
Other,inclined
Resistance,significantAntiproliferativeActivityAgainstHumanTumorCellLines
Other,metastasectomy
Other,matched
Other,individualRiskOfRecurrence
Other,intravoxelIncoherentMotionParameters
Other,decreasesInMortalityRates
Interval,group2
Distance,totalHemoglobinConcentration
Other,pregnancy
Other,tumorNecrosisFactor
Other,roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients
Other,hematoxylin
Other,mortalityRates
Other,505PercecntOfAnalyzedCases
Areola,haveAssociatedWithNippleAreolaComplexInvolvementInPatientsWithBreastCancer
Other,hasDeveloped
Other,maintenanceOfErCancerStemCells
Other,mostCommonUltrasonographicFindings
Other,0.029
Other,medications
Other,goodCorrelationBetweenErAnalysedWithCytAtDiagnosisAnalysedWithIhcInArchivedFfpeTissueFromSameTumour
Other,inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases
Consensus,consensus
Endocrine,evidenceForEfficacyOfGonadotropin-releasingHormoneAgonists
Other,mitosis
Other,childbearingReasonsIncluding
Other,focal
Other,known
Other,oftenDebated
Other,features
Other,that
Other,obtainedFromPatientsWithBreastCancer
Other,screened
Exposure,itsDiagnosticPerformance
Appearance,interestingClassOfCompoundsWithVariedDegreesOfStructuralComplexity
Skin,level
Other,252Percecnt
Other,earlyBreastCancer
Other,riskOfEndometrialPathologies
Other,advancedComputationalSystems
Skin,alarmingLevelGlobally
Other,itEffects
Incorporation,presentedWorkForFeatureExtraction
Other,cancerDeathAmongWomenWorldwide
Hyperglycemia,effectOfSex
Other,downregulatedIn
Craniotomy,incompleteExcisionOfMalignantTissues
Other,womenWorldwide
Other,clinicalCharacteristicsOfCareOfBreastCancerPatients
Other,currentCancerResearch
Other,promoterMethylationInCertainTypesOfHumanTumors
Other,healthcareUtilization
Interference,shouldEstablishedBetweenScreeningWithImplementationOfRobustQualityAssurance
Other,CA-VTE
Other,riskFactors
Other,willTestedThroughEuropeanMyPersonalBreastScreening
Other,0.001
Other,1H
Other,postmenopausalwomen
Other,stat1RecruitmentToEralphaPromoterRegion
Other,painless
Other,faSignalingNetwork
Sleep,age
Other,efficientlyCross-linked
Macroadenomas,macroadenomas
Dysplasia,kaplan-meierRegressionMethods
Other,30DoublingTimesNecessary
Other,hasWidelyUsed
Other,roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers
Other,thusCritical
Other,positivelyCorrelated
Food,betterAccessToAtertiaryCancerCenter
Other,diagnosed
Other,regulationOfNras
Other,theirInteractions
Other,evidenceForbenefits
Other,20PercecntForGata3
Cavernous,cavernousMalformation
Granuloma,veryRareCaseOfTraumaticBreastNeuroma
Other,1722Comments
Appearance,defectStudies
Other,advantageOfHigh-throughputLuminexTechnique
Other,womenWithMore70PercecntOfPatientsTreatedWithHormonalTherapy
Other,similarSeriousAdverseEvents
Resistance,aggressiveCourseOfHer2Cancer
Other,bevelledEdges
Modulators,protectiveEffectOfAspirinForCardiovascularEventsDuringItsConcomitantUseWithSelectiveEstrogenReceptorModulatorsInPreventionOfBreastCancer
Other,chosen
Other,completionOfReproductivePlans
Other,mustAddressedDuringCancerGeneticCounselingConsultations
Other,expressed
Appearance,99PercecntAccuracyInTermsOfClassification
Other,asianPopulation
Other,preservationOfBiomarkerExpressionInOldFfpeTumour
Other,normalDucts
Other,evaluation
Other,thereforeAdministered
Other,systems
Other,typicalFeaturesIncludingFibrocysticBreastDisease
Other,brcanessPhenotype
Other,spanishWomenWithLungCancer
Plasticity,mass
Other,estrogenReceptor
Other,debated
Other,21Percecnt
Other,currentlyUnclear
Plasticity,massSize
Other,ranging
Other,descriptive-analyticCross-sectionalType160FemalePatientsWasselected
Other,outcomesAmongKoreanPatients
Other,unnecessarySubsequentExaminations
Other,decreased
Other,progressionOfSeveralTypesOfNeoplasms
Appearance,conclusion
Other,aggressive
Other,cancerType
Other,initialTreatmentAfterWhich
Interval,keyCircadianClockGene
Other,immunohistochemicalTechniques
Other,publicHealthChallenge
Appearance,unusualCaseOfPtosis
Other,65Months
Appearance,diagnosticAccuracy
Other,inColorectalCancersHaveConducted
Other,doublingTimeOfOccult
Plasticity,sensitivityOf786PercecntRespectively
Neuropathy,poorAdhesion
Resistance,tamoxifenResistance
Other,protected
Other,indicationsForRisk-reducingSurgery
Other,uterine
Distance,firstCaseOfGaslessRobot-assistedNipple-sparingMastectomyInPatientWithEarlyBreastCancer
Other,assessed
Other,challenging
Issues,changesToIntimateIssuesIncludingSexualHealth
Other,collection
Incorporation,study
Literacy,definitionOfHealthLiteracy
Other,breastCancerGenes
Other,overallLowOfSixCirculatingMirnas
Regions,differentFunctionRegions
Other,foundInPcosCohortThanInComparisonCohort
Other,olderAdultsWith
Other,mapped
Other,haveUsed
Other,bl1-subtypeTriple-negativeBreastCancer
Other,drugExtravasation
Seroma,updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery
Other,proteinS-100
Other,metastatic
Other,nextMade
Other,it
Other,theirAdjacentMatchedTissues
Sprays,increaseWithNumberOfSprays
Other,proportion
Appearance,inConclusionDownregulatedInBreastCancer
Other,fundamental
Other,125DogSeraSamplesIncluding75MammaryTumourSera
Other,based
Other,ronReceptorTyrosineKinase
Resistance,course
Other,couldDetectedEarly
Other,moreLikely
Other,similar
Interference,tripleAssessmentFollowed
Other,tissueTumors
Other,breastCancerImagingSetting
Other,loss
Other,subgroupOfMacroprolactinomas
Other,inMarch2014BroadcastedAsPart
Other,patientsByTrastuzumab-pretreatment
Other,4
Other,oncology
Other,SVM
Other,prevalent
Other,areUsed
Other,studiesFocused
Other,patternsOfAssociationResults
Other,specificAreas
Other,fourTypesOfBreastCancer
Appearance,case
Other,large
Other,roleOfCircularRnas
Other,historyOfBreast-conservingSurgery
Other,provedByExperimentalEvidence
Other,whenActiveUse
Other,advancedBreastCancerBearingMutationsInGenesInvolvedInPi3k/ark/mtorSignalingPathway
Other,particularlyPertinent
Other,news
Interval,group
Baseline,reducedBaselineCardiacFunction
Distance,firstPatientsWithPathologicallyTumor-freeNodes
Other,secondSurgery
Other,stained
Other,mood
Literacy,influenceOfHealthLiteracyOnPathwayToCancerDiagnosis
Other,expressedSeparately
Appearance,betterDiagnosticAccuracyThanFfdm
Other,visualInspection
Other,conclusionsInPractice-basedSampleOfCa-vtePatientsAssociatedWithSimilarBleedingRisksToWarfarin
Obstacle,majorObstacleInTreatmentOfTriple-negativeBreastCancerWithConventionalChemotherapeuticAgents
Distance,firstFiveFacebookOpenBreastCancerGroupsInYear2016
Other,humanBiofluid
Interference,delivery
Other,accessToEarlyDiagnosis
Other,trend
Other,aspect
Membrane,panel
Relapse,continuousPatternOfRelapse
Other,expression
Other,healthySubjects
Sleep,threeYearsBeforeAge64Years
Resistance,theirCytotoxicityAgainstTwoHumanTumorCellLines
Other,90PercecntOfPatientsWithRecurrence
Other,possibility
Other,localTherapyOfBreastCancer
Other,three6-monthPeriods
Drugs,cardiotoxicityOfHer2-targetedDrugs
Other,patientsOnAromataseInhibitors
Other,prominent
Other,240Months
Other,51Days
Other,robust
Other,determinantGenesRelatedToBreastCancerFromInitialGeneExpressionData
Other,history
Extract,cause
Other,agents
Other,statisticallySignificantValuesAt4Cells/7MlBlood
Provision,personalizedFollow-upSchemes
Other,mostCommonAgentsUsedInBreastCancerTreatment
Other,yetHasFirmlyEstablishedInClinicalPractice
Other,China
Other,findings
Interval,cycle
Other,harmfulorHarmlessTissues
Other,2002
Other,adenosine-inducedScEnrichment
Areola,sideEffects
Other,treatment
Other,RNAs
Sleep,youngAge
Other,willDifferentRegardingSubtypeAtDiagnosis
Other,worldwide
Resistance,associationsOfPhysicalActivityInGlobalHealthInBreastCancerSurvivors
Other,brainMetastases
Other,painlessLumpInBreastAccountingFor688PercecntOfPatients
Other,newValue-basedHealthcareParadigm
Other,trastuzumabInitiation
Other,satisfied
Document,nudeMouseModel
Other,substantialDiscordancesBetweenPrimaryTumors
Other,opportunitiesForResearchInBreastSurgery
Other,clinicalVariablesAmongDifferentGroups
Resistance,activityOfCellProliferationInBreastCancerCells
Other,thenClassifiedBySupportVectorMachines
Other,992PercecntOfCases
Other,context
Other,vitalRoles
Metformin,metforminTreatment
Interval,thanCapecitabineGroup
Other,howeverSwitched
Other,structureChanges
Other,lapatinibCombined
Other,inexpensiveTechnique
Other,group-basedTrajectoryModelling
Incorporation,inPresentWorkHasProposedForBreastCancerDiagnosis
Other,numberOfSegmentInvolved
Other,therebyFrequentlyNeglected
Other,second
Other,driven
Other,iterativelyModified
Other,theirInteractionsLikeGene-gene
Other,potentialClinicalBiomarker
Other,recognizedAsCtcIn1Of15HealthyBloodSamples
Provision,constitutiveActivationOfDownstreamSignalingPathway
Other,found
Other,hasReported
Other,expressionLevelsOfProteinsAssociatedWithEpithelial-mesenchymalTransition
Similarities,similaritiesInInformationalNeedsByCancerType
Other,AUC
Neuropathy,patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction
Other,brca1Levels
Provision,canDetectedWithHelpOfVariousProfilingMethods
Document,literatureForFamiliesWithCdh1Mutations
Other,1YearTo5Years
Other,complementaryApproaches
Consensus,consensusOnAssociationBetweenExposureToDdt
Other,notablyUpregulatedWithinPatients
Other,expressionInBreastCancer
Other,surveillanceData
Resistance,potentialApplicationForDiagnosisOfCancerInFuture
Other,localExcision/lumpectomy
Other,68Percecnt
Other,26894Ca-vtePatientsTreatedWithAnticoagulants
Other,referral
Other,documented
Other,inherited
Mother,conflictBetweenCareOfMother
Other,prognosisMoreAccurately
Other,knowledgeOfM
Other,hasProven
Other,especiallyPromising
Other,newDesignDouble-layerCapacitors
Other,understand
Obstacle,thusWouldCrucialForApplicationOfPreventiveStrategies
Other,invasiveCarcinomaBreast
Other,rocCurveAnalysis
Other,accurateDiagnosisOfBreastCancerSubtypes
Other,summarisedIn2018WorldCancerResearchFund/americanInstituteForCancerResearchReportGlobalPerspective
Relapse,betterResults
Other,riskFactorForLung/bronchusCancer
Other,increasingNumber
Other,resistantToExonuclease-mediatedDegradation
Appearance,differenceBetweenDifferentBreastCancerSubtypes
Other,neutralEffects
Other,largestCancerPatientCohortStudies
Other,safety
Other,radiomicsScore
Other,neuralNetworkClassifier
Other,havePublished
Other,canHeavilyInfluenced
Other,inheritableBi-objectiveCombinatorialGeneticAlgorithm
Other,uncover
Other,inHumanBreastCancerHasReported
Other,symptom
Other,qualitativeApproach
Other,formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
Interference,mostFrequentLateComplication
Other,connected
Other,mustIndividualized
Provision,secondLeadingCause
Other,abbreviatedMriProtocols
Other,patientsWithHistoryOfBreastSurgery
Other,kind
Other,receivedWithoutSurfaceModification
Other,roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers
Other,shouldPerformed
Nanoplatform,especiallyModifiedOntoSurfaceOfNanoplatformForActiveHer2-targing
Other,concerned
Carcinoma,inflammatoryCarcinoma
Probe,handheldProbeCapable
Other,involved
Other,howeverSignificant
Other,potentialTreatmentStrategy
Other,childHealth
Other,yetUnclear
Provision,hasReducedThroughoutLastDecades
Other,events
Other,pcrResults
Sleep,ageOfTreatmentMethods
Other,misdiagnosis
Other,hasInconsistent
Other,specificCircumstances
Relapse,medianTimeToCnsRelapseOf31Years
Other,cases
Other,veryComplexDisease
Other,patientsWithMetastaticBreastCancer
Other,cross-linked
Other,peakInRecurrenceRisk
Sleep,fastDayBefore
Other,hereditaryCausesOfChorea
Other,logisticregressions
Other,us
Other,newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies
Collision,familyImpact
Other,europeanCountries
Other,canines
Other,inAdditionMeasured
Other,alongsideRoutineMethodEmployedOnTexture
Exposure,performance
Other,dopamineAgonists
Other,womenAcrossGlobe
Interval,field
Other,7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Other,definiteDiagnosisParticularlyInSmallBiopsies
Other,multipleBiological
Markers,mightCrcMarkers
Other,inclusions
Other,lumbarSegments4-6
Other,haveProposed
Other,thereforeRequired
Other,estimated
Other,patientsWithMAmongThem
Other,greaterthanorequaltoReduction
Incorporation,resultsOfStudy
Other,Europe
Appearance,difference
Endocrine,amongOlderAdultsObservedForBreastCancerInFemalesForProstateCancerInMales
Other,qualityOfLife
Functionality,oncogenicFunctionalityOfSpc24InBreastCancerProgression
Other,preclinicalPhase
Other,preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi
Provision,unnecessaryFollow-upVisitsForWomenWithVeryLowRisks
Other,migrationAbilitiesOfHelaCells
Other,mostFrequentlyObserved
Other,majorConcerns
Other,canCategorizedIntoSubtypesOfLuminalA
Resistance,drugResistance
Quantification,whole-tumorSamplingOfDiseaseBurden
Other,timeOfTheirAppointmentwithDoctor
Other,couldDeveloped
Other,furthermoreEnhanced
Other,characterized
Other,bindingToBreastCancerCellsInVitro
Plasticity,univariateSensitivityAnalysesresults
Extract,cssBenefit
Relapse,reductionOfRelapse
Other,mayDetected
Other,importance
Other,changes
Other,inclusionCriteria
Other,canOnlyDiagnosedOnPresentationOfSymptoms
Other,markerBands
Other,number
Other,howeverMuchLower
Other,blood
Other,detectionOfCancer
Other,modified
Appearance,inConclusionMajorHereditaryBreastCancerGenesIrrespectiveOfAgeAtDiagnosisInJapaneseWomen
Other,therapeuticBenefits
Other,establishedOncogene
Images,high-resolutionImages
Skin,at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
Other,tumorEasily
Relapse,betterPrognosisInBl1Patients
Mother,mustIndividualizedWithEmphasisOnOptimalCareOfMother
Resistance,activity
Other,145Percecnt